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Primary open-angle glaucoma is the most common form of glaucoma and the second-
leading cause of preventable blindness worldwide. Although timely diagnosis and proper 
adherence to therapeutic regimen prevent blindness, patient nonadherence continues to be 
the greatest challenge to effective treatment. Preliminary research suggested that culturally 
interactive education delivery may increase patient adherence. However, this education 
intervention had not occurred with glaucoma treatment. The transtheoretical model of 
behavior change served as the framework for this study. The research questions addressed 
the effect that glaucoma education provided by a culturally competent patient navigator had 
on patient knowledge of glaucoma, adherence to medication use, and follow-up 
appointment attendance. This quantitative study had a longitudinal design with archival 
data from 206 Russian Eastern European immigrant patients. The control group had a 
standard appointment with an ophthalmologist, and the experimental group had an 
interactive educational experience with a patient navigator after the standard appointment. 
The navigator administered the Glaucoma Knowledge Index at three time points: before the 
appointment (T1), after the appointment (T2), and at a 1-month follow-up (T3). The 
intervention group showed a statistically significant increase in glaucoma knowledge 
retention at T2 and T3. However, this increase in knowledge did not correspond to a 
statistically significant difference in patients’ adherence to follow-up eye exam attendance 
or ocular medication adherence. The outcome of this study may form the basis for 









MSW, New York University, 2014 
BA, CUNY Brooklyn College, 2007 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 









Table of Contents 
List of Tables ...................................................................................................................... v 
List of Figures .................................................................................................................... vi 
Chapter 1: Introduction to the Study ................................................................................... 1 
Background ................................................................................................................... 2 
Problem Statement ........................................................................................................ 5 
Purpose of the Study ..................................................................................................... 6 
Research Questions and Hypotheses ............................................................................ 9 
Nature of the Study ..................................................................................................... 11 
Theoretical Framework ............................................................................................... 11 
Definitions of Terms ................................................................................................... 12 
Assumptions ................................................................................................................ 14 
Scope and Delimitations ............................................................................................. 15 
Limitations .................................................................................................................. 16 
Significance ................................................................................................................. 16 
Summary ..................................................................................................................... 17 
Chapter 2: Literature Review ............................................................................................ 19 
Literature Search Strategy ........................................................................................... 20 
Theoretical Foundation ............................................................................................... 21 
Transtheoretical Model ......................................................................................... 21 
The Stages of Change ........................................................................................... 24 
Current Applications of TTM ............................................................................... 25 
 
ii 
Limitations of TTM .............................................................................................. 26 
Glaucoma .................................................................................................................... 28 
Structure of the Eye .............................................................................................. 28 
The Visual Pathway .............................................................................................. 29 
Glaucomatous Damage ......................................................................................... 29 
Primary Open-Angle Glaucoma ........................................................................... 30 
Diagnosing POAG ................................................................................................ 32 
Treating POAG ..................................................................................................... 33 
Barriers in Adherence Treating POAG ................................................................. 35 
Physician–Patient Therapeutic Relationship ............................................................... 36 
Factors Leading to Glaucoma Treatment Nonadherence ............................................ 38 
Poor Education and Patient Knowledge ............................................................... 39 
Difficulties With Ocular Medication Instillation .................................................. 41 
Approaches to Improve Adherence and Persistence ............................................. 43 
Challenges of Health Care Delivery in Nonacculturated Russian Immigrant 
Communities ......................................................................................................... 44 
Filling the Gap in Glaucoma Care Delivery ............................................................... 46 
Professional Service Gap ...................................................................................... 47 
Patient Navigators ................................................................................................. 48 
Reasons Providing Education Has Not Worked in Prior Research ............................ 51 
Summary and Conclusion ........................................................................................... 53 
Chapter 3: Research Method ............................................................................................. 54 
 
iii 
Research Design and Rationale .................................................................................. 54 
Research Questions and Hypotheses .......................................................................... 55 
Methodology ............................................................................................................... 57 
Population Description .......................................................................................... 57 
Procedures for Recruitment and Participation ...................................................... 58 
Data Collection ........................................................................................................... 58 
Sampling and Sampling Procedure ....................................................................... 61 
Instrumentation and Operationalization of Constructs ......................................... 63 
Data Analysis Plan ...................................................................................................... 64 
Threats to Validity ...................................................................................................... 67 
Threats to Internal Validity ................................................................................... 67 
Threats to External Validity .................................................................................. 67 
Ethical Procedures ...................................................................................................... 68 
Agreement to Gain Access to Data ....................................................................... 68 
Treatment of Archival Data .................................................................................. 68 
Summary ..................................................................................................................... 69 
Chapter 4: Results ............................................................................................................. 70 
Data Collection ........................................................................................................... 72 
Results ......................................................................................................................... 73 
Preparing Data for Analysis .................................................................................. 73 
Descriptive Statistics ............................................................................................. 73 
Testing Statistical Assumptions ............................................................................ 75 
 
iv 
Glaucoma Knowledge ........................................................................................... 80 
Summary ..................................................................................................................... 91 
Chapter 5: Discussion, Conclusions, and Recommendations ........................................... 93 
Interpretation of Findings ........................................................................................... 93 
Improvement of Glaucoma Knowledge ................................................................ 94 
Adherence to Follow-Up Eye Appointments ........................................................ 96 
Adherence to Using Prescribed Ocular Medications ............................................ 98 
Limitations of the Study .............................................................................................. 99 
Recommendations ..................................................................................................... 102 
Implications for Social Change ................................................................................. 103 
Conclusion ................................................................................................................ 104 





List of Tables 
Table 1. Frequencies of Demographic Variables .............................................................. 74 
Table 2. Descriptives for Continuous GKI at All Three Time Points .............................. 75 
Table 3. GKI Pairwise Comparisons Between Time Points ............................................. 77 
Table 4. GKI Estimated Marginal Means by Group for All Time Points ......................... 81 
Table 5. Chi-Square Cell Breakdown for Time 3 Follow-Up Attendance by Group ....... 89 





List of Figures 
Figure 1. Consort Diagram for the Study Design ............................................................... 8 
Figure 2. Results From Power Analysis ........................................................................... 62 
Figure 4. Histogram of GKI at Time 1 for the Entire Sample .......................................... 77 
Figure 4. Histogram of GKI at Time 2 for the Entire Sample .......................................... 78 
Figure 5. Histogram of GKI at Time 3 for the Entire Sample .......................................... 78 
Figure 6. Histograms of Glaucoma Knowledge by Time and Group ............................... 79 
Figure 7. Means for Glaucoma Knowledge at Time 1 by Group ..................................... 83 
Figure 8. Means for Glaucoma Knowledge at Time 2 by Group ..................................... 84 
Figure 9. Means for Glaucoma Knowledge at Time 3 by Group ..................................... 85 
Figure 10. Glaucoma Knowledge Index at Time 2 and Time 3 by Group ....................... 86 




Chapter 1: Introduction to the Study  
Glaucoma causes progressive damage to the optic nerve and is the leading cause 
of irreversible blindness worldwide (Abdull et al., 2016). Blindness from glaucoma is 
avoidable with early diagnosis and appropriate, sustained life-long treatment (Abdull et 
al., 2016; Kyari et al., 2016). With adequate knowledge, adherence to follow-up care, and 
proper ocular medication utilization, patients can prevent blindness from this disease. 
However, many patients fail to adhere to treatment recommendations and lose most of 
their vision (Nowak & Smigielski, 2015).  
Poor outcomes in patients with glaucoma often stem from barriers to care, such as 
difficulty traveling to appointments, poor access to eye care, the prohibitive cost of eye 
exams and treatment, and ocular medication noncompliance (Davis et al., 2018; Johnson 
et al., 2016; C. X. Zheng et al., 2016). Another significant reason for nonadherence to 
treatment is a lack of understanding of the glaucoma diagnosis and its severity, especially 
when the patient is asymptomatic (Nowak & Smigielski, 2015; van Zyl et al., 2015; C. X. 
Zheng et al., 2016). The absence of symptoms in almost all glaucoma patients can 
increase the risk of treatment nonadherence (De-Gaulle & Dako-Gyeke, 2016). 
Nonadherence to ocular medication and follow-up medical care leads to irreversible 
vision loss, preventable falls and injuries, decreased quality of life, social isolation, and 
depression (Tan et al., 2018; D. D. Zheng et al., 2018). 
Chapter 1 presents a discussion of the background of the research and the problem 
statement as well as the purpose of the study, research questions, and hypotheses. I 
provide the theoretical framework, the nature of the study, definitions, assumptions, 
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scope, delimitations, and limitations. The chapter concludes with the significance of the 
study and a summary. 
Background 
Glaucoma is a chronic optic neuropathy resulting in visual field defects, 
progressive vision loss, and blindness (Zhang et al., 2015). Glaucoma is the second-
leading cause of irreversible blindness in the United States, with New York State reported 
to have one of the highest rates of glaucoma (National Academies of Sciences, 
Engineering, and Medicine, 2016; Prum et al., 2016). Given the rapidly aging U.S. 
population, the National Academies of Sciences, Engineering, and Medicine (2016) 
predicted that glaucoma would increase by 50% to 3.36 million people in 2020. The 
estimated annual U.S. health care costs associated with glaucoma are $2.9 billion, with 
the increasing prevalence of glaucoma expected to cause a significant economic and 
quality-of-life burden (Callinan et al., 2017). The prevalence of this disease varies greatly 
across ethnic and racial groups (Gupta et al., 2016; Hark et al., 2017; Komolafe et al., 
2013; Nowak & Smigielski, 2015; Prum et al., 2016). 
Primary open-angle glaucoma (POAG) is the most common form, affecting 2.2 to 
2.7 million Americans (Mahabadi et al., 2019). Asymptomatic until the optic nerve 
damage is severe, POAG develops slowly and is associated with poor drainage of the 
aqueous humor, leading to elevation of intraocular pressure and subsequent damage to 
the optic nerve ganglion cells (Dietze et al., 2019). The prevalence of POAG is often 
higher in individuals of African descent, with minimal data available about POAG rates 
among Eastern Europeans who have immigrated to the United States (Murdoch et al., 
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2020; Nowak & Smigielski, 2015). However, in 2010, POAG was highest among Eastern 
European immigrant populations and represented 23.9% of those with POAG worldwide 
(Centers for Disease Control and Prevention [CDC], 2015; Nowak & Smigielski, 2015; 
Quigley & Broman, 2006).  
Patient nonadherence to physicians’ prescribed therapeutic regimen is the greatest 
challenge to treating patients with glaucoma effectively (Varma et al., 2016). Several 
barriers contribute to patient nonadherence to glaucoma treatment and follow-up care. 
Patients with glaucoma have reported difficulty finding transportation to eye care 
appointments without access to a car, someone to accompany them, and the social 
support needed to comply with follow-up care (Ibrahim et al., 2015; C. X. Zheng et al., 
2016). Additionally, patients might lack education about their condition, experience 
significant discomfort from ocular glaucoma medications, receive inadequate eye drop 
instillation training, and deny the risk of blindness due to the asymptomatic nature of 
glaucoma (Davis et al., 2018; Thompson et al., 2015; Varma et al., 2016).  
Livne et al. (2017) demonstrated that patient education is an essential component 
of the care provided by health care professionals. Educating patients about their chronic 
conditions will lead to improved patient participation in self-care, increased quality of 
life, and better psychological and physiological outcomes. Patient education also 
contributes to decreased stress, anxiety, and costs associated with blindness and falls. 
Livne et al. discovered that education influenced patients’ motivation to follow 
recommendations, consequently improving treatment compliance. Despite these benefits, 
patient teaching has received little attention as, after receiving a chronic glaucoma 
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diagnosis, patients receive insufficient information about their illness and appropriate 
care (Killeen et al., 2020; Livne et al., 2017). 
Economic forces have driven a private-practice focus on productivity and 
efficiency, with performance metrics pushing physicians to see higher volumes of 
patients with less time for each (Rider et al., 2018). Additionally, frequent cuts in 
managed care reimbursements force physicians to work faster to maintain their income, 
decreasing the time spent in meaningful interactions and compromising the traditional 
patient–doctor relationship (Rider et al., 2018). In the 1995 Commonwealth Fund Survey, 
41% of physicians noted a decline in the amount of time spent with patients (Dugdale et 
al., 1999).  
Among patients complying with ocular medication treatment, inadequate 
education about proper administration of glaucoma drops leads to ineffective medication 
delivery and continuing eye damage (Davis et al., 2018). Unlike traditional medical 
specialties, where the role of education belongs to nurse professionals, the field of 
ophthalmology does not have a nursing specialty. Accordingly, there is a significant 
patient education gap in ophthalmological health care delivery specific to glaucoma. 
Despite efforts made to justify the role of ophthalmic nurses, there has been nothing done 
to propel this specialty forward (Moradi, 2016). 
In the 1990s, Freeman developed the concept of a patient navigator to reduce 
barriers to breast cancer care in Harlem, New York (Freeman & Rodriguez, 2011). Since 
then, primary care settings have adopted the approach, as a trained person (patient 
navigator) engages with patients to educate them and improve health care access (Peart et 
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al., 2018). Recently, patient navigator duties have extended to addressing barriers patients 
have to care, such as providing education about their conditions and coordinating 
appointments. These services are especially important for vulnerable populations who 
find their access to care compromised by a range of geographic, demographic, 
socioeconomic, or cultural characteristics (Peart et al., 2018). In a 1-year randomized, 
controlled trial, Hark, Johnson, et al. (2016) evaluated the impact of a patient navigator 
on glaucoma eye care follow-up adherence in an urban community setting versus an 
office-based setting. The researchers found that help from a patient navigator did not 
increase the likelihood of keeping follow-up appointments; however, the authors believed 
this was due to inconsistent follow-up appointment schedule and patient self-selection. 
Hark, Johnson, et al. did not analyze the value of patient navigators in educating patients 
about glaucoma or ocular medication administration.  
Research has indicated that half of glaucoma cases are undiagnosed, and this rate 
is even higher among at-risk populations (Fudemberg, Amarasekera, et al., 2016). 
Without appropriate treatment and routine long-term follow-up care, glaucoma can cause 
irreversible vision loss (Hark et al., 2017). Patient nonadherence to glaucoma treatment 
exacerbates the disease, leading to irreversible blindness (Hahn & Truman, 2015). 
However, when patients and medical providers adhere to recommended standards of care, 
the risk of blindness significantly declines (Hahn & Truman, 2015; Sleath et al., 2014).  
Problem Statement 
The asymptomatic nature of POAG means the disease frequently remains 
undiagnosed until the advanced stages (Hark, Waisbroud, et al., 2016). Early diagnosis is 
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critical to preventing blindness; by the time patients become symptomatic, severe and 
irreversible damage has already occurred. Despite aggressive therapy, initiating available 
treatment at late diagnostic stages cannot stop disease progression (Zhang et al., 2015). 
POAG most affects individuals who are at risk for socioeconomic disadvantage and are 
unable to schedule regular eye screenings due to their lack of knowledge, inability to 
understand the diagnosis, and scarcity of financial means for copayments and travel 
(Sapru et al., 2017). Certain ethnic groups, such as Russian Eastern Europeans, have a 
genetic predisposition to developing POAG (Nowak & Smigielski, 2015).  
Research evaluating education’s effectiveness in improving health-related 
outcomes showed that education was a means to intentionally engage patients in self-care 
while promoting health equality in at-risk populations (Hahn & Truman, 2015). The 
provision of such education requires high-level patient–physician engagement (Hark, 
Waisbroud, et al., 2016). However, due to the economic pressures on medical providers, 
many physicians no longer have the resources for this time-consuming process (Rider et 
al., 2018). The gap in research addressed by the current study pertained to the 
effectiveness of education provided by the patient navigator in patients’ native language 
on their knowledge and understanding of glaucoma, as well as their adherence to follow-
up care and prescribed ocular medications. To reduce this gap, I analyzed archival data 
from a private glaucoma clinic in New York. 
Purpose of the Study 
The purpose of this quantitative study was to examine the effect of education 
about glaucoma through a patient navigator on patient knowledge of glaucoma and 
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patient adherence to follow-up care. The process entailed examining a randomly split 
convenience sample of 206 participants into two equal groups to compare whether 
additional education in one group produced an effect on glaucoma knowledge, adherence 
to ocular medication use, and follow-up appointment attendance. Group 1 was a control 
group that received a standard exam; Group 2 received the standard exam and additional 
education provided by a patient navigator. Participants were from the Russian Eastern 
European immigrant population at a private glaucoma specialty clinic in New York. 
Determining patients’ glaucoma knowledge entailed the administration of the Glaucoma 
Knowledge Index (GKI) at three time points: before the exam (T1), immediately 
following the exam in Group 1 and the exam and additional education in Group 2 (T2), 
and at a 1-month follow-up appointment (T3). The goal of gathering data at T1 was to 
measure patients’ baseline information about glaucoma. T2 served as a manipulation 
check to determine whether the provided education was effective and whether there were 
differences between Group 1 and Group 2 in knowledge comprehension and retention 
after the appointment. Finally, data gathered at T3 showed whether participants had a 
significant, persistent, meaningful change with a lasting effect for subsequent 
recommendation to health care providers. Also evaluated at the 1-month follow-up 










Figure 1 presents a detailed consort diagram for the study design. The study 
outcome could be key to encouraging ophthalmological practices treating glaucoma 
patients to hire and train culturally competent staff to fulfill the role of patient navigators. 
Additionally, the findings could bring awareness to the growing need for patient 
education among vulnerable, at-risk populations and encourage other researchers to 
conduct more extensive studies in other specialties of ophthalmological patient care.  
Research Questions and Hypotheses 
This was a quantitative study with five research questions (RQs).  
RQ1: Are there significant differences between pretest and posttest in knowledge 
of glaucoma as a function of whether patients are provided with additional education? 
H01: There are no significant differences between pretest and posttest in 
knowledge of glaucoma. 
Ha1: There are significant differences between pretest and posttest in knowledge 
of glaucoma. 
RQ2: Are there significant differences between the two groups in knowledge of 
glaucoma as a function of whether patients are provided with additional education?  
H02: There are no significant differences between the two groups in knowledge of 
glaucoma. 
Ha2: There are significant differences between the two groups in knowledge of 
glaucoma. 
RQ3: Is there an interaction effect between time and group in knowledge of 
glaucoma as a function of whether patients are provided with additional education?  
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H03: There is no interaction effect between the time and group in knowledge of 
glaucoma. 
Ha3: There is an interaction effect between the time and group in knowledge of 
glaucoma. 
RQ4: Is patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up appointment at T3 dependent on whether patients were exposed to education 
about glaucoma? 
H04: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up appointment at T3 is not dependent on whether patients were exposed to 
education about glaucoma. 
Ha4: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up treatment at T3 is dependent on whether patients were exposed to education 
about glaucoma. 
RQ5: Is patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 
medication at T3 dependent on whether patients were exposed to education about 
glaucoma? 
H05: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 
medication at T3 is not dependent on whether patients were exposed to education about 
glaucoma. 
Ha5: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 




Nature of the Study 
This study was conducted to examine the effect of patient education about 
glaucoma through a patient navigator on patient adherence to follow-up care among 
Russian Eastern European immigrant patients at a private glaucoma clinic in New York. I 
used archival data with an experimental, descriptive design to evaluate whether education 
about glaucoma provided by a patient navigator affected patient knowledge of glaucoma, 
adherence to medication utilization, and attendance at follow-up appointments. 
Determining the experimental descriptive component was by pre- and postlevels of 
knowledge, medication use, and attendance to follow-up appointments. The findings 
from the study were sufficient to answer five RQs with the independent variable (IV) of 
education about glaucoma and the three dependent variables (DVs) of patient knowledge 
about glaucoma, attendance at follow-up appointments, and adherence to using 
prescribed ocular medications.  
Theoretical Framework 
The theoretical framework for this study was the transtheoretical model (TTM), or 
the stages of change developed by Prochaska and DiClemente in the 1970s (Prochaska et 
al., 1992). This model holds that individuals have an enormous capacity to change 
harmful or undesirable behavior. This integrative, biopsychosocial model incorporates 
the stages through which individuals pass to achieve sustained behavioral change 
(Prochaska et al., 2013). The five stages are precontemplation, contemplation, 
preparation, action, and maintenance. Researchers have often used TTM to address 
behavioral changes, such as smoking cessation, drinking, or overeating. Inherent in this 
12 
 
model is the recognition and acceptance that change unfolds over time (Prochaska et al., 
2013). TTM serves as a guide to assess an individual’s readiness to act on a new, 
healthier behavior, providing knowledge to inform providers about patients’ readiness to 
accept new information. Providers can determine whether patients are ready to receive 
information about the benefits of implementing the new, changed behavior or whether 
this information might overwhelm them. 
After receiving a novel diagnosis of glaucoma, which requires highly involved 
care and multiple follow-up visits, patients in the asymptomatic early stage might be 
resistant to adopting new behavior. TTM helped me determine why some patients are 
motivated to change their behavior and others are resistant. In accordance with the TTM 
model, because change is a phenomenon of time, bringing these patients back in 1 month 
for a follow-up appointment helped me to evaluate the sustainability of behavioral 
change.  
Definitions of Terms 
The following terms received mention in this study: 
Adherence to follow-up treatment: I measured adherence to glaucoma follow-up 
treatment by the participants’ attendance to a mandatory follow-up examination as 
requested by the ophthalmologist. In the past, adherence to glaucoma follow-up treatment 
meant attending the follow-up medical exams and agreeing to do the diagnostic testing, 
as directed by the diagnosing physician (Movahedinejad & Adib-Hajbaghery, 2016).  
Adherence to the use of prescribed medication: Measuring adherence to the use of 
prescribed medication was done by the information gathered at the follow-up exam. This 
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term describes the extent to which patients administer their glaucoma medications exactly 
as prescribed (Newman-Casey, Blachley, et al., 2015; Newman-Casey, Shtein, et al., 
2016). 
Education about glaucoma: Education about glaucoma referred to the time the 
patient navigator spent with the participants after the ophthalmologist gave them the 
diagnosis. This education involved reviewing what POAG uses as an eye model, a 
description of how the disease progresses, the meaning of elevated intraocular pressure, 
and the importance of adherence to the ophthalmologist-prescribed treatment as well as 
the necessity of attending the follow-up exams. All communication was available in 
Russian and in English to ensure that patients could comprehend the provided 
information.  
Glaucoma: Glaucoma includes several complex eye disorders causing permanent 
degeneration of the optic nerve and retinal cells, progressing to visual compromise and 
eventual blindness (Wiggs & Pasquale, 2017). Marked by an increase in intraocular 
pressure, glaucoma is largely asymptomatic, leading to late diagnosis. The disease is the 
second-leading cause of irreversible blindness in the United States (Prum et al., 2016).  
Glaucoma Knowledge Index: Celebi (2018) developed GKI in assessing 
knowledge and awareness of glaucoma among subjects with glaucoma and their normal 
first-degree relatives. Administered in the current study at T1, T2, and T3, the GKI 
provided information on patients’ knowledge and understanding of glaucoma.  
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Knowledge of glaucoma: Evaluating patient knowledge about glaucoma in the 
current study was through the GKI (see Celebi, 2018). This instrument is a way to gather 
basic information about an individual’s glaucoma knowledge.  
Primary open-angle glaucoma: POAG is one of the two main types of glaucoma, 
the other being closed-angle glaucoma. POAG affects peripheral vision first, with gradual 
and progressive visual field loss unnoticed until significant and permanent damage has 
occurred (Greco et al., 2016).  
Assumptions 
One assumption of this study was that the private glaucoma clinic collected the 
archival data correctly, following the appropriate assessment protocol. This assumption 
was necessary because I was unable to confirm the means of data collection by the clinic. 
Another assumption was that people want to get better and take their medications as 
prescribed. I also assumed that patients understood they were participating under their 
free will and that if they had refused participation, the clinic would not have withheld or 
denied medical care. It was my assumption that the participants were honest in the way 
they answered questions and reported the use of the prescribed medications.  
Assumptions for the repeated measures analysis of variance (ANOVA) included 
normality, sphericity, and homogeneity of variance. Testing assumptions for the chi-
square test of independence were that each participant contributed data to only one cell 
and that the chi-square was a nonparametric test that did not assume a normal 
distribution. More detailed descriptions of the statistical test assumptions are in 
Chapter 3.  
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Scope and Delimitations 
McGregor et al. (2018) found poor outcomes in patients with glaucoma often 
attributed to barriers to care, such as limited knowledge about glaucoma, poor access to 
and utilization of eye care, lack of adherence to follow-up exams, and inadequate 
medication administration. The researchers identified additional barriers to glaucoma 
management and treatment to be denying the risk of blindness, lower education level, 
poor patient–provider communication, and low health literacy levels. These factors likely 
contribute to disparities related to glaucoma detection, treatment, management, and 
follow-up eye care. The scope of the current study was to evaluate whether exposure to 
education through a patient navigator would have an effect on patient knowledge about 
glaucoma as well as patient adherence to follow-up appointments and prescribed ocular 
medication. The archival data were from a private glaucoma clinic in New York serving 
the Russian Eastern European immigrant population.  
One delimitation was that the studied population was limited to high-risk Russian 
Eastern European immigrants residing in New York, in geographically isolated 
communities with significant socioeconomic disparities. Another delimitation associated 
with this study was that although the practice collected data on all patients, I analyzed 
data only on new patients with a first-time glaucoma diagnosis. This decision was a 
means to eliminate possible contamination by prior diagnosis or education that I could 




The chief limitation of using archival data was the inability to obtain the 
information directly; therefore, I could not assume that the results would be entirely 
accurate. Using archival data presents a researcher with multiple issues, including the 
inability to establish authenticity (Frankfort-Nachmias & Nachmias, 2008). The current 
study was limited in the generalizability of findings because the sample, consisting only 
of Russian immigrants residing in New York, did not reflect the general population. 
Participant data were from one glaucoma specialty practice that used convenience 
sampling. There may also have been a positive cultural bias. Because the patient 
navigator was a Russian immigrant, participants might have wanted to please her and put 
forth more effort than usual. Finally, it was not possible to assess some of the barriers that 
might have prevented participants from attending follow-up exams unrelated to 
nonadherence. Examples of these components included participant mortality, illness, or 
lack of transportation. 
Significance 
This study was a means to determine whether providing glaucoma education at 
the doctor’s visit through a patient navigator increased patient adherence to follow-up 
care. I examined the extent to which education by a bilingual patient navigator affected 
patients’ knowledge of glaucoma at the time of the exam (T1 and T2) and the 1-month 
follow-up appointment (T3). Also investigated was the effect of education on adherence 
to follow-up care as determined by the rate of participants’ return for their necessary 1-
month follow-up exam appointment (T3).  
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Vision deterioration and blindness can have devastating effects on quality of life 
for patients, their families, and their friends. Irreversible blindness can be frightening, 
overwhelming individuals’ capacity to maintain their independence, pay for needed 
medical care, retain employment, and provide for themselves and their families. Schakel 
et al. (2017) identified links between vision loss and life-altering falls, diminished social 
functioning, lower educational attainment, and poor emotional well-being. The authors 
also found that individuals with vision impairment are at a higher risk for depression, 
anxiety, and other psychological problems. Schakel et al.’s findings showed that as the 
population ages, the health care costs and economic burdens related to blindness increase, 
indicating the importance of vision for health and social well-being.  
The negative health consequences associated with vision loss extend well beyond 
the eye and visual system (Glen & Crabb, 2015). The societal costs are substantial, 
thereby indicating the need for prevention, especially for diseases in which blindness is 
avoidable (Gracitelli et al., 2015). Some of the functional and affective consequences of 
vision loss are remediable. The present study contributed to positive social change by 
showing the extent to which education provided at the physician’s office by a trained 
patient navigator after a glaucoma diagnosis affects patient knowledge about glaucoma 
and treatment adherence to follow-up care, both ways to prevent avoidable vision loss.  
Summary 
The purpose of this quantitative study was to examine the effect of education 
about glaucoma through a patient navigator on patient knowledge of glaucoma and 
patient adherence to follow-up care. Poor outcomes in patients with glaucoma often stem 
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from barriers to care, such as limited knowledge about eye disease, poor access to eye 
care, and medication noncompliance (Tan et al., 2018). A limited understanding of the 
insidious and asymptomatic nature of glaucoma and the necessity for lifelong treatment 
could contribute to follow-up eye care nonadherence. When patients comply with 
appropriate treatment, they can manage their glaucoma to prevent blindness. 
Understanding the relationship between glaucoma education, participants’ retained 
knowledge, and adherence to follow-up care could indicate whether a trained patient 
navigator should provide such education as a standard practice at diagnosis. 
Chapter 1 contained the purpose, rationale, theoretical framework, and 
background of this study. It also included the research questions and hypotheses, nature 
of the study, definitions, assumptions, limitations, and delimitations. The chapter 
concluded with the significance of the study, the summary, and the potential for social 
change. Chapter 2 contains an examination and a review of current literature most 
relevant to the research problem of this study. 
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Chapter 2: Literature Review 
Vision loss significantly impacts participation in daily living, imposes substantial 
costs on families, and places a burden on the health system and economy, making it a 
significant concern for public health (Congdon et al., 2004; Glen & Crabb, 2015; 
Gracitelli et al., 2015; Smith et al., 2019). Vision impairment leads to decreased 
involvement in interpersonal interactions and relationships, impacting domestic, 
community, and social life (Glen & Crabb, 2015; Gracitelli et al., 2015; Zhang et al., 
2015). The exacerbation of consequential comorbidities, such as an increased risk of 
mental health problems and falls, results from the inability to move about unaided (Zhang 
et al., 2015). POAG, the most common form of glaucoma, is a chronic, insidious disease 
with serious reductions in vision occurring only in the advanced stages (Harasymowycz 
et al., 2016; Kapetanakis, 2016). POAG is associated with elevated intraocular pressure 
due to aqueous humor outflow dysfunction, and successful treatment is available with 
proper medication administrational and adherence to follow-up eye care (Harasymowycz 
et al., 2016). About half of glaucoma patients do not adhere to their medications, leading 
to poor clinical outcomes and irreversible vision loss (Newman-Casey et al., 2018).  
The definition of patient nonadherence is a patient’s failure to follow a prescribed 
course of treatment by the attending physician and discontinued or improper use of 
prescribed ocular medications (Newman-Casey, Blachley, et al., 2015; Newman-Casey, 
Shtein, et al., 2016; Wilhelm et al., 2018). Because therapy adherence is a primary 
determinant of POAG treatment success, failure to do so is a serious problem affecting 
not only the patient but also the health care system (Wilhelmsen & Eriksson, 2019). A 
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significant consequence of nonadherence is that the individual will not obtain an optimal 
pharmacotherapeutic benefit, thereby facing increased optic nerve deterioration leading to 
preventable blindness (Newman-Casey, Blachley, et al., 2015; Newman-Casey, Shtein, et 
al., 2016). Ethnic and age disparities in poor adherence to glaucoma treatment 
disproportionately affect older, underserved, vulnerable, and minority populations (Chua 
et al., 2015; Newman-Casey et al., 2018). Therefore, it is imperative to focus research on 
increasing efforts and understanding the importance of implementing strategies to prevent 
avoidable vision loss. Such inquiry could lead to improved eye health among members of 
underserved communities who might experience barriers in access to eye care 
(Harasymowycz et al., 2016; Kapetanakis, 2016).  
The purpose of the current study was to explore the effect of glaucoma education 
provided by a patient navigator on patient knowledge of glaucoma, patient adherence to 
ocular medication use, and follow-up appointment attendance in the Russian Eastern 
European immigrant population at a private glaucoma specialty clinic in New York. In 
this chapter, I cover the strategies used to search for literature, the theoretical foundation, 
and the study’s framework. The research gaps addressed were the effects of education 
provided by a patient navigator on patients’ understanding of their disease, the patients’ 
attendance during follow-up appointments, and proper utilization of ocular medications.  
Literature Search Strategy 
I conducted a thorough and exhaustive literature search using Cochrane Library, 
MEDLINE Medscape, PubMed, PsycINFO, PsycARTICLES, Google Scholar, and the 
Walden University library. I limited the search to sources published between 2015 and 
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2020. The initial search was for peer-reviewed articles. Subsequently, I accessed the 
CDC and the National Academies of Sciences, Engineering, and Medicine websites for 
current information and statistics related to glaucoma prevalence among vulnerable 
populations. After screening 8,634 abstracts, I selected 302 articles containing 
information on pathophysiology, treatment, and education relevant to ophthalmological 
settings specializing in glaucoma treatment. The primary keywords searched were 
glaucoma, patient education, compliance, and adherence. I included a combination of 
search terms with Boolean operators, such as POAG glaucoma, glaucoma AND patient 
education, glaucoma AND treatment compliance, glaucoma AND treatment adherence, 
glaucoma AND patient instruction, treatment refusal, treatment nonadherence, patient 
persistence, patient acceptance of health care, self-efficacy, self-care, chronic illness 
AND self-management, treatment motivation, and stages of change. I did not use any 
language restrictions.  
Theoretical Foundation 
This study’s theoretical framework was the TTM with its stages of change. This 
theory was appropriate to understand the process of intentional behavioral change in 
patients’ self-management of glaucoma. Noncompliance with follow-up treatment and 
medication usage in chronic disorders, such as glaucoma, is a significant obstacle to 
helping patients achieve and maintain their eyesight.  
Transtheoretical Model  
Prochaska and DiClemente developed TTM, or the stages of change model, to 
explore the process of change for smoking cessation (DiClemente & Prochaska, 1982, 
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1998; Prochaska & Vellcer, 1997). Prochaska and DiClemente were studying the 
differences between individuals who experienced quitting smoking on their own versus 
quitting with assistance. They created a model of intentional change, focusing on 
understanding the decision-making process of the individual.  
In a 2-year longitudinal study, DiClemente (1981) examined why some 
individuals could quit smoking independently and others could not. TTM applies to 
behavior change through educational interventions for patient care (DiClemente et al., 
1985; Prochaska et al., 2013). Individuals with chronic illnesses can struggle with the 
awareness that their behavior might be exacerbating the problem; therefore, merely 
suggesting they change their behavior might not be sufficient (DiClemente & Velasquez, 
1994). Such individuals need to make the conscious decision to change their actions, 
producing a positive outcome through sustained behavior change (DiClemente et al., 
1985; DiClemente & Hughes, 1985; DiClemente & Velasquez, 1994).  
TTM draws from other theories regarding the process of decision-making, such as 
Janis and Mann’s (1977) inquiry into decisional balance and Bandura’s (1977) work on 
self-efficacy. Janis and Mann proposed that changing one’s behavior begins with a 
decisional balance, when an individual considers consequences from desirable to 
undesirable effects before making a decision. This balance is known as the pros and cons 
of change. The individual then decides whether to make a behavioral change (Janis & 
Mann, 1977). The goal of this process is to facilitate a realistic assessment of behavior 
change’s value and potential alternatives. After deciding to change their behavior, the 
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individuals will then progress through the stages of change (DiClemente & Prochaska, 
1982, 1998; Prochaska et al., 2013).  
Bandura’s (1977, 1982, 1986) self-efficacy theory refers to individuals’ belief in 
their capacity to execute behaviors necessary to produce specific results. Bandura (1977, 
1982, 1986) defined self-efficacy as the core of human functioning, reflecting an 
individual’s ability to execute required behavior under manageable and challenging 
circumstances. Bandura further discussed that knowledge is not enough for individuals to 
complete a task under challenging circumstances; instead, they must have the conviction 
that they can complete it (Bandura, 1986, 1997; D. A. Cook & Artino, 2016). Bandura 
(1986, as cited in Cook & Artino, 2016) referred to this concept as reciprocal causation, 
in which the functioning of one component depends in part on the functioning of the 
other. Individuals who score high on self-efficacy scales tend to exert more effort and 
persistence in the face of difficulties and adversities than those with lower self-efficacy 
(Artino, 2012; Cook & Artino, 2016).  
DiClemente and Prochaska (1982, 1998) built upon the concepts of decisional 
balance and self-efficacy to propose that changing a behavior is a deliberate process, and 
different people are in different stages of change and readiness. Although DiClemente 
and Prochaska’s work began with individuals trying to quit smoking, the researchers 
noticed that a precipitating event frequently leads to an internal drive to consider any 
behavior change. Additionally, their findings indicated that such change happens 
predictably. When studying the relationship between individuals’ readiness and their 
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ability to quit smoking, DiClemente et al. (1985) observed that participants’ utilized the 
processes of change, subsequently identifying a relationship between the two variables. 
Upon committing to change, an individual must replace old behavior with new 
behavior (Prochaska et al., 1992). Sustainable change does not happen randomly; rather, 
it occurs in a predictable way (DiClemente & Velasquez, 1994; Prochaska et al., 1994). 
Additionally, sustainable change occurs based on individuals’ ability to implement an 
internal change in their behavior due to their readiness and willingness to change 
(Prochaska et al., 1994). TTM addresses the five stages that individuals must navigate to 
achieve lasting behavior change. The theory provides an understanding of why some 
people can change their behavior and others cannot (DiClemente & Prochaska, 1982; 
Prochaska et al., 1994). 
The Stages of Change 
The stages of change in the TTM model are precontemplation, contemplation, 
preparation, action, and maintenance. In the precontemplation stage, individuals are 
unaware that their behavior might be harmful and have no intention of changing the 
behavior (Prochaska & Vellcer, 1997). In this stage, implementing the decisional balance 
of pros and cons is a means to discuss the benefits of healthy behavior with the 
individuals. Contemplation is when individuals begin to consider the change. In this 
stage, the individuals are aware of the problem and desire to change their behavior; 
however, they experience ambivalence about implementing change. The preparation 
stage is when individuals are ready for change and begin to alter their behavior. In the 
preparation stage, encouragement and continued explanation of pros and cons are helpful 
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to assist individuals along the continuum of change. The action stage involves individuals 
making lifestyle modifications and actively changing their behavior. To successfully 
navigate this stage, individuals need self-efficacy to avoid temptation and relapse. Last, 
during the maintenance stage, individuals continually channel efforts to maintain 
behavior change and prevent relapse. 
Individuals move through the process of behavior change through an interplay of 
behavioral and experiential processes (Van Cappellen et al., 2018). Although the 
concepts of TTM operate in an integrative loop, individuals who relapse will enter the 
contemplation stage and resume the process from that point (Grol & Wensing, 2020). For 
pervasive internalized change, individuals will have to develop self-efficacy to avoid 
relapse.  
Current Applications of TTM 
TTM has been used in health and medical research to explain or predict a person’s 
success or failure in achieving a proposed behavior change (Friman et al., 2017; 
Prochaska et al., 2013). TTM has been applied in research related to developing positive 
health-behavior changes in chronic disorders in which behavior modifications are critical 
to maintaining patients’ well-being. According to prior research, the most consistent 
positive outcome of interventions to improve self-care has been improved self-efficacy, 
which is an important element of self-management (R. J. Adams, 2010; Friman et al., 
2017). This finding emerged from studies on sustained physical exercise, reducing 
obesity based on changing unhealthy eating habits, and medication adherence in diabetic 
patients (Friman et al., 2017; Kelley et al., 2016). 
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TTM has been a means to understand how individuals attempting to change their 
behavior experience stages of readiness to accept such change (Segall, 2018). K. T. Liu et 
al. (2018) noted that “movement through these stages often occurs in cyclic rather than 
linear patterns because many individuals must make several attempts to change their 
behavior before they meet their goals and move to the next stage” (p. 7). In moving 
through these stages, people can use different strategies and techniques depending on 
their motivation and goals (K. T. Liu et al., 2018; Segall, 2018).  
Nigg et al. (2019) examined how TTM predicts behavior change processes and 
guides interventions among individuals interested in making changes related to physical 
activity. The authors found that intervention efforts focusing on processes to change 
cognitions related to barriers in self-efficacy and decisional balance led to sustainable 
changes and a renewed focus on the processes. Shakiba et al. (2018) arrived at similar 
findings from using a TTM-based intervention to increase fish intake as an intervention 
for combating cardiovascular disease in individuals in Iran. Findings from both studies 
indicated that when individuals have positive thoughts and attitudes toward the new 
behavior and the process of change, they are motivated to stay engaged with the new 
behavior, becoming more self-efficacious and less likely to relapse (K. T. Liu et al., 
2018; Nigg et al., 2019; Shakiba et al., 2018). TTM suggests that behavior changes occur 
based on knowledge that leads to attitude shifts (DiClemente & Prochaska, 1998). 
Limitations of TTM  
J. Adams and White (2004) conducted a nonsystematic critical review to 
investigate the effectiveness of TTM-based activity promotion interventions. They found 
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that a stage-based activity promotion program was effective in encouraging the adoption 
of behavioral change in the short term (fewer than 6 months); however, long-term 
adherence was limited and disappointing. Additionally, Horwath et al. (2013) suggested 
that only individuals who possessed self-liberation demonstrated significant differences 
consistently over time, as indicated in their longitudinal study on individuals transitioning 
to five or more servings of fruit and vegetables each day.  
Bradshaw et al. (2016) supported Horwath et al.’s (2013) findings in a study of 
individuals from poorly functioning families, which included high levels of conflict, 
disorganization, and weak affective and behavioral control preparing for personal 
changes that positively impacted and improved overall family functioning. Bradshaw et 
al. found a need to consider other variables when examining individuals’ readiness to 
make a sustainable change. The consideration of other variables was because there are no 
set criteria for determining a person’s stage of change and no clear sense for how much 
time is needed for each stage or how long a person can remain in a stage (J. Adams & 
White, 2004; Bradshaw et al., 2016; Horwath et al., 2013). 
 Additionally, Gourlan et al. (2016) discussed that TTM incorporates a one-size-
fits-all approach, which does not suit all individuals and cannot explain variation. 
Therefore, TTM is not generalizable to all social and cultural populations. Moreover, 
Marshall and Biddle (2001) stated that TTM’s core constructs are of limited use based on 
the assumption that individuals make coherent and logical plans in their decision-making 
process, which is not always true. Additionally, Marshall and Biddle argued that most 




Structure of the Eye  
Encompassing several diseases, glaucoma is characterized by increased pressure 
of the eye. Glaucoma leads to atrophy of the optic nerve and, if left untreated, causes 
irreversible blindness. The human eye splits into two segments: the anterior and the 
posterior chamber (Addo et al., 2016). The anterior chamber is in the front segment of the 
eye and holds the cornea, iris, ciliary body, and lens immersed in a fluid-like substance 
called the aqueous humor (Addo et al., 2016; Sridhar, 2018). The posterior segment 
encompasses the back two thirds of the eye and includes the vitreous humor, retina, 
choroid, and optic nerve (Addo et al., 2016). The aqueous humor is a clear, thin fluid in 
the anterior chamber of the eye continuously produced and drained as it transports 
nutrients to the cornea and the lens while giving the eye its shape. The aqueous humor 
plays an essential role in eye health because it maintains eye pressure. Any abnormality 
or malfunction in the drainage system of the aqueous humor leads to an impaired outflow 
of the aqueous humor, causing elevated intraocular pressure.  
Measuring intraocular eye pressure is by determining the difference between 
atmospheric pressure and the pressure inside the eye (Castro et al., 2016). This number is 
a clinical parameter for assessing the health of the eye. The standard for normal eye 
pressure is between 12 and 25 mm Hg, with anything equal to or greater than 26 mm Hg 
considered elevated intraocular pressure. The elevated intraocular pressure affects all eye 
structures, causing optic nerve neuropathy that may lead to blindness. Generation and 
maintenance of intraocular eye pressure is by the aqueous humor circulation system 
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(Tamm et al., 2015). Secreted from the epithelial layers of the ciliary body, the aqueous 
humor exits the eye through the trabecular meshwork or the uveoscleral outflow 
pathways. When there is a defect in the outflow pathway, the aqueous humor builds up, 
increasing intraocular eye pressure (Tamm et al., 2015).  
The Visual Pathway 
The visual pathway begins in the posterior segment with the retina and the optic 
nerve. The retina, lining the back of the eye, comprises superimposed neurons called rods 
and cones, which connect and pass the information to the optic nerve (Fahy et al., 2016; 
Nguyen & Ethier, 2015; Wiggs, 2015). Also known as the second cranial nerve, the optic 
nerve sends the visual information from the retina to the brain (Freud et al., 2016). The 
optic nerve is the only part of the central nervous system that leaves the cranial cavity and 
is clinically visible (Freud et al., 2016; Martínez-Marcos & Sañudo, 2019). The optic 
nerve gathers information from the retina and sends it to the brain. Composing the optic 
nerve are retinal ganglion cells consisting of over one million nerve fibers (Freud et al., 
2016; Martínez-Marcos & Sañudo, 2019), converging at the part of the retina where the 
optic nerve exits the eye; this is the optic nerve head (Freud et al., 2016). On retinal 
images, the optic nerve head looks like a crater with a cup-to-disc ratio correlated to the 
health of the nerve (Orlando et al., 2017).  
Glaucomatous Damage 
In the presence of glaucoma, elevated intraocular pressure exerts direct 
mechanical damage to the optic nerve head, destroying nerve fibers along the outer rim of 
the optic nerve (Chaturvedi et al., 2018). This pressure causes the cup to enlarge in a 
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vertical oval pattern, increasing the cup-to-disc ratio (Burgoyne, 2015; Chaturvedi et al., 
2018). Optic disc cupping enlargement leads to corresponding sight loss that affects the 
peripheral vision only; thus, most affected people are unaware of this disease (Abdullah 
et al., 2016; Almazroa et al., 2017). Due to the brain’s ability to compensate for vision 
loss, patients might not detect the change until they have lost a significant portion of their 
eyesight (Hark et al., 2017; Hark, Waisbroud, et al., 2016). The asymptomatic nature of 
glaucoma and the brain’s compensation means patients might not notice vision loss or 
experience “tunnel vision” until they have lost 40% of nerve fibers (Hark, Waisbroud, et 
al., 2016; Lavinsky et al., 2017). Vision loss from glaucoma is irreversible (Hark et al., 
2017; Hark, Waisbroud, et al., 2016; Lavinsky et al., 2017). The four types of primary 
glaucoma are open-angle, angle-closure, normal-tension, and congenital.  
Primary Open-Angle Glaucoma  
Distinguishing glaucoma entails measuring the angle between the iris makes and 
the cornea. In POAG, this angle is open; instead, there is a block in the trabecular 
meshwork, a system of canals that allows the aqueous humor to circulate (B. Liu et al., 
2018). Therefore, although the angle is open, once the canals malfunction and the 
aqueous humor does not drain properly, the intraocular eye pressure begins to increase 
(Kubicka-Trząska, 2020; B. Liu et al., 2018). Nerve damage occurs as the intraocular eye 
pressure increases and exerts pressure against the nerve fibers of the optic nerve, 
depriving it of oxygen and nutrients (Kubicka-Trząska, 2020). Vision loss from POAG 
begins with peripheral vision and slowly moves centrally (B. Liu et al., 2018). 
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Most people with POAG feel fine and do not notice a change in their vision at 
first because the initial loss of vision is on one side (peripheral), and they maintain visual 
acuity, or sharpness, until late in the disease (Weinreb et al., 2016). The lack of 
symptoms in POAG delays detection and diagnosis. Typically, POAG progresses slowly; 
by the time it becomes symptomatic, severe and irreversible damage has occurred in one 
or both eyes (Pan & Varma, 2011; Weinreb et al., 2016). The rate of progression of the 
visual field defect varies in patients, and treatment might not completely halt the visual 
field loss, despite aggressive therapy (Weinreb et al., 2016). 
Minimal data are available on POAG rates in the Russian Eastern European 
immigrant population within the United States. However, in 2010, POAG incidence was 
highest among this immigrant population, representing 23.9% of those with POAG 
worldwide (CDC, 2015; Nowak & Smigielski, 2015; Quigley & Broman, 2006). The 
prevalence of POAG pseudoexfoliation glaucoma is much higher among White 
Americans. In the United States, the most recent 2010 statistics on POAG 
pseudoexfoliation glaucoma are 66% White, 19% Black, 8% Hispanic, and 7% other 
races (National Eye Institute, 2019). Because Russian Eastern European immigrants 
identify as White Americans, it is fair to assume they are part of the 66%. Genetic defects 
account for a significant prevalence of this disease in some ethnic and racial groups. 
More specifically, a strong genetic association has emerged with the lysyl oxidase-like 1 
(LOXL1) gene in many POAG patients with pseudoexfoliation glaucoma (Janjua et al., 
2017). Although genetic predisposition for phenotypic expression of glaucoma is better 
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understood, intraocular eye pressure is currently the only modifiable risk factor to prevent 
progressive optic neuropathy and blindness from glaucoma (Mohsen et al., 2016). 
Diagnosing POAG 
Although elevated intraocular pressure is a consistent risk factor for the presence 
of glaucoma, several population-based studies showed intraocular pressure to be lower 
than 22 mm Hg in 25% to 50% of individuals with glaucoma (Behkam et al., 2019). 
Therefore, increased intraocular pressure may predispose individuals to POAG. However, 
the mere presence of elevated intraocular pressure is insufficient for the diagnosis 
(Behkam et al., 2019; Mohsen et al., 2016). A full ophthalmologic workup is necessary to 
diagnose POAG accurately. A comprehensive eye exam involves intraocular pressure 
measured with Goldmann applanation tonometry, the international standard for ocular 
pressure assessment in ophthalmic research and clinical practice, gonioscopy, optic nerve 
assessment visual field testing (Mohsen et al., 2016). Pachymetry, the measurement of 
central corneal thickness, can help interpret intraocular pressure measurements and 
stratify the patient’s risk of developing glaucomatous visual field defects. The 
ophthalmologist can assess the extent of optic nerve involvement or damage via direct 
ophthalmoscopeIndirect ophthalmoscopy allows the ophthalmologist to view 
glaucomatous changes, including cupping or other signs of damage on the optic nerve, 
such as optic nerve hemorrhage or focal loss of the nerve fiber layer.  
The extent of diagnostic involvement is exhaustive, with diagnosis requiring a 
highly trained ophthalmologist who is a glaucoma specialist. General ophthalmologists or 
those not specializing in glaucoma frequently underdiagnose glaucoma, either missing 
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the diagnosis or as a result of patients missing their appointments (Kabat & Sowka, 2016; 
Nayak et al., 2011). Due to the narrowness of this subspecialty and lengthy training time, 
few glaucoma specialists are available in low socioeconomic and underserved areas 
(Rodgers et al., 2017). The absence of specialists coupled with geographic 
maldistribution of practice locations leaves many underserved, vulnerable, and at-risk 
populations without care to prevent late-stage POAG glaucoma, leading to blindness.  
Treating POAG 
At present, the only intervention proven effective for treating POAG and ocular 
hypertension is lowering intraocular eye pressure to prevent further progression of optic 
nerve neuropathy and visual loss (Weinreb et al., 2018). The American Academy of 
Ophthalmology Preferred Practice Pattern recommends lowering the intraocular pressure 
to a level that will slow the disease progression and prevent functional impairment from 
the disease (Feder et al., 2016; Glaucoma Research Foundation, 2018). The most 
effective way to achieve these recommendations is by using pressure-lowering topical 
ocular medications (Y. Liu & Allingham, 2017). Often the first line of medical therapy, 
prostaglandin analogues reduce intraocular pressure by lowering outflow resistance, 
resulting in increased aqueous humor flow through the uveoscleral pathway (Diaconita et 
al., 2018; Nguyen & Ethier, 2015). Topical ocular medications are the most common due 
to their convenience, simplicity, and noninvasive nature, and the patient’s ability to self-
administer (Diaconita et al., 2018; Weinreb et al., 2020). However, these medications can 
cause local adverse effects, such as conjunctival hyperemia, elongation and darkening of 
eyelashes, loss of orbital fat, and periocular skin pigmentation (Diaconita et al., 2018). 
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Adverse effects of glaucoma medications are frequent, occurring immediately or 
much later (Weinreb et al., 2020). The most common ocular complaint with these 
medications is transient stinging and burning (Davis et al., 2018; Farkouh et al., 2016). 
Other frequently reported symptoms include fluctuating vision, dry and itchy eyes, and 
retinal detachment (Nguyen & Ethier, 2015; Weinreb et al., 2020). These symptoms are 
bothersome but mostly toleratable. Approximately 80% of eye drops can pass through the 
nasolacrimal duct into the nasal mucosa and its microvasculature, causing systemic side 
effects (Farkouh et al., 2016; Stavert et al., 2015). These side effects include intestinal 
cramps, tinnitus, hearing dysfunction, diarrhea, bronchospasm, cardiac irregularities, 
tachycardia, arrhythmia, elevated blood pressure, depression, lethargy, fatigue, kidney 
stones, and anaphylaxis (Farkouh et al., 2016; Janjua et al., 2017; Stavert et al., 2015).  
Laser or incisional surgeries are necessary if medications no longer adequately 
work and other treatment modalities cannot keep the intraocular pressure under control 
(Elhofi & Lolah, 2017). For extremely nonadherent patients or those with severe disease, 
surgery is required (Sahoo et al., 2018). Trabeculectomy is the most-performed incisional 
surgical procedure to lower intraocular pressure. This surgical glaucoma procedure 
disrupts the globe’s integrity and produces a plethora of complications, most of which are 
vision-threatening (Elhofi & Lolah, 2017; Sahoo et al., 2018; Yook et al., 2018). 
Therefore, postoperative success rates are low with the possibility of developing a flat 




Barriers in Adherence Treating POAG 
Medical pharmacological treatments are effective in controlling glaucoma 
(Mehuys et al., 2019; Souto et al., 2019). Unfortunately, patient adherence to glaucoma 
treatment and medication is an ongoing challenge (Mehuys et al., 2019). Frequent 
glaucoma follow-up visits are essential to evaluate patients’ response to the ocular 
medications and to assess any adverse side effects (Feng et al., 2016; Mehuys et al., 
2019). Such frequent follow-up visits have served as obstacles to proper disease 
management (Lazcano-Gomez et al., 2016; Mehuys et al., 2019). Moreover, unlike oral 
medicines, eye drops require patients to use proper techniques for successful 
administration (Lazcano-Gomez et al., 2016). Poorly established eye drop instillation and 
nonadherence lead not only to reduced treatment effectiveness but also increased costs 
from chronic disease (Feng et al., 2016; Souto et al., 2019). More than half of POAG 
patients omitted 10% of their doses, while another 15% omitted half of their doses (Gao 
et al., 2018; Souto et al., 2019). Newman-Casey, Robin et al. (2015) found that nearly 
half of individuals filling glaucoma prescriptions discontinued ocular hypotensive 
therapies within 6 months. Improper instillation of ocular medications can also lead to 
eye infection and other traumas due to overdose or touching the eye with the eye drop 
container (Bacon et al., 2016; Gao et al., 2018). Poor tolerance and systemic side effects 
of ocular medications are crucial noncompliance issues, especially when the primary 
disease is asymptomatic (Feng et al., 2016; Gao et al., 2018).  
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Physician–Patient Therapeutic Relationship 
The physician–patient relationship is a keystone of care, the medium for 
establishing a positive therapeutic climate and alliance to achieve a common goal 
between practitioner and patient (Alkureishi et al., 2016). In the context of this 
relationship, practitioners collect and evaluate clinical data, offer education and 
diagnoses, achieve compliance, and provide healing, patient activation, and support 
(Alkureishi et al., 2016). The patient–practitioner connection is a dynamic relationship 
evolving much like health care, from traditional to electronic (Cajander & Grünloh, 
2019). Physicians and health care providers have a significant impact on a patient’s 
compliance and therapeutic effects; therefore, treatment discussion and communication 
are integral to any diagnosis (Colloca, 2017; Hansen & Zech, 2019). When making a 
chronic diagnosis or dispensing information on therapeutic benefits, the provider’s choice 
of words, clinical setting, and transparency of expected side effects will impact the 
patient’s emotional and physical response (Heisig et al., 2015; Vögtle et al., 2016). The 
way physicians communicate a diagnosis and discuss possible symptoms and treatment 
can shape the course of the illness for years, directly affecting the disease progression and 
outcome (Colloca et al., 2018; Howick et al., 2018). In a study on implications of placebo 
effects for clinical practice, Evers et al. (2018) found that providers’ positive framing 
resulted in advantageous neurobiological and psychological mechanisms of expectancies 




The widespread implementation of electronic health records helped create 
convenience and care continuity, promote patient participation, and improve health 
outcomes (Cajander & Grünloh, 2019). However, there is little proof about the 
development and creation of physician–patient collaborative processes with electronic 
health record implementation (Cajander & Grünloh, 2019; Zulman et al., 2020). 
Concerns have arisen over physicians paying more attention to the patients’ e-chart on 
the computer screen than to the real patient during a clinical interaction (Alkureishi et al., 
2016). Although electronic health records provide infrastructure for billing purposes, the 
physicians face obstacles in completing the electronic chart and often do so while a 
patient is still in the exam room (Alkureishi et al., 2016). The workflow process prevents 
the patient from checking out and making a follow-up appointment until the physician 
has completed and closed that part of the chart. Although created to help physicians 
complete charts faster and make billing easier, electronic health records introduced a 
clinical burden that has become a leading cause of physician burnout (Collier, 2017; 
Ehrenfeld & Wanderer, 2018).  
Mounting income pressures and economic forces driving the health care industry 
to focus on productivity, coupled with increased administrative demands of electronic 
health records, have led to a decline in quality time between physicians and patients 
(Rider et al., 2018). The 1995 Commonwealth Fund Survey found that 41% of physicians 
reported a decline in the amount of time spent with patients (Dugdale et al., 1999). 
Reduced exam room time significantly impedes the human connection central to clinical 
care, exacerbating physician and patient dissatisfaction (Zulman et al., 2020). 
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Furthermore, these deteriorating physician–patient relationships create a lack of empathy, 
leading to worsening illness on both emotional and physiological levels, known as the 
“nocebo response” (Ehrenfeld & Wanderer, 2018; Rider et al., 2018).  
Nocebo response is the opposite of a placebo effect and has a substantially 
negative impact on patient adherence to medical treatment (Barsky, 2017). Nocebo 
effects can result from negative experiences and outcomes deriving from the clinical 
encounters (Czerniak et al., 2016). The content and the means of presenting information 
to patients in a clinical setting during a diagnostic procedure influence the nocebo 
response (Nestoriuc et al., 2016). These effects can also emerge in clinical practice by 
negative expectations relating to discussions of possible side effects from prescribed 
medications as well as treatments and progression of the disease (Bartley et al., 2016; 
Petrie & Rief, 2019). The nocebo effect has been apparent in situations with little time for 
physicians to spend with patients, a pervasive lack of discussions and conversations, a 
language or cultural barrier, and no opportunity for patients to ask questions and receive 
education about their illness (Petrie & Rief, 2019). Patients experiencing a nocebo effect 
tend to have negative psychological and neurobiological mechanisms of accepting their 
diagnoses, subsequently becoming nonadherent or even discontinuing an appropriate 
therapy. The nocebo effect has considerable costs in terms of impaired patient quality of 
life, nonadherence, and adverse health outcomes (Rezk & Pieper, 2017). 
Factors Leading to Glaucoma Treatment Nonadherence 
Despite the availability of effective glaucoma therapies, such as ocular 
medications and adherence to follow-up care to reduce vision loss from glaucoma, 
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nonadherence in patients is as high as 80% (Robin & Muir, 2019). Poor adherence and 
poor clinical outcomes disproportionately impact the most vulnerable members of 
society, including culturally isolated, older, and minority populations (Hark et al., 2019; 
Newman-Casey et al., 2018). Adherence is a complicated multifactorial phenomenon 
influenced by multiple variables, including patient, therapy, condition, health system, and 
socioeconomic factors and comorbidities (Robin & Muir, 2019). The World Health 
Organization (2003) defined adherence as “the extent to which a person’s behavior taking 
medication, following a diet, or executing lifestyle changes corresponds with agreed 
recommendations from a health care provider” (p. 3). 
Factors that influence adherence to glaucoma medications derive from multiple 
sources. Scholars have consistently identified significant barriers to adherence, including 
poor communication between physicians and patients, patients’ lack of knowledge about 
the long-term effects of glaucoma, problems reading instructions, difficulty with drops 
instillation or poor technique, forgetting to take the medication, polypharmacy, health 
care/medication costs, and medication-related adverse effects (Tamrat et al., 2015). 
Poor Education and Patient Knowledge  
Inadequate knowledge about glaucoma, glaucoma treatment, and consequences of 
deficient treatment may all contribute to nonadherence or nonpersistence (Robin & Muir, 
2019). Celebi (2018) conducted a cross-sectional survey of glaucoma knowledge in 
patients and their first-degree relatives, finding that 50% of nonadherent respondents 
cited knowledge about glaucoma as a barrier. Similar to other asymptomatic chronic 
illnesses, such as systemic hypertension, patients with glaucoma do not have clear 
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endpoints that tangibly signal improvement. Patients may not fully understand eye 
pressure and its effects (Celebi, 2018).  
Research shows that a tailored approach centered around the patient with initial 
education about glaucoma and the importance of using the eye drops can improve 
motivation and compliance (Tse et al., 2016). Physicians who are burdened by economic 
pressures, time-consuming electronic health record platforms, and overbooked schedules 
due to an overwhelming shortage of glaucoma specialists face significant time constraints 
to deliver effective educational interventions (Alkureishi et al., 2016). Inadequate time 
creates a void in the current paradigm of how a single physician is responsible for 
medical decision-making, surgical intervention, counseling and educating patients, and 
coordinating care in a complex medical system (Newman-Casey et al., 2018; Tse et al., 
2016).  
To address the inadequate time providers spend with patients, Newman-Casey et 
al. (2018, 2020) created a technology-based, individually tailored behavior change 
program designed to motivate people with glaucoma to improve their medication 
adherence. The implemented program consisted of paraprofessionals providing brief, 
glaucoma-specific motivational interviewing and counseling. The intervention did not 
improve patients’ eye drop instillation self-efficacy or overall health activation. The time 
paraprofessionals spent with patients was brief, not education-focused, and not offered in 
a culturally competent environment where non-English speaking patients received 
information in their native language (Newman-Casey et al., 2020). The findings indicated 
that lower income, lower educational attainment, and a higher level of glaucoma-related 
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distress all predicted less adherence to glaucoma medications. Shah (2018) provided 
leaflets and online tools to patients to evaluate the effectiveness of such educational tools; 
however, these tools did not produce long-term adherence. Shah identified a need to relay 
educational information needs verbally, as many patients respond favorably to 
discussion-based conversation and prefer a personalized, one-on-one consultation with 
their provider.  
Difficulties With Ocular Medication Instillation 
A critical contributing factor to continued vision loss from glaucoma is poor 
medication adherence (Newman-Casey, Blachley, et al., 2015). Newman-Casey, 
Blachley, et al.’s (2015) literature review of glaucoma treatment showed dismal rates of 
medication adherence; in one longitudinal 4-year study, only 48% of 1,234 glaucoma 
patients filled half of their prescribed medications. Medication adherence is difficult to 
measure, especially when based on patient self-reports. Prior studies on medication 
adherence indicated three main reasons for medication nonadherence (Ehrlich et al., 
2019; Newman-Casey et al., 2019). Twenty to 30% of patients never fill the first 
prescription, and 50% never fill the second prescription. Between 20% and 50% of 
patients try to use their glaucoma medications but fail to instill them correctly (Newman-
Casey et al., 2019). Therefore, it is critical to reassess patients during their follow-up 
appointments to differentiate eye drop efficacy from lack of adherence (Kim et al., 2018). 
A patient might report adherence but use a medication incorrectly or not take any 
medication due to difficulty self-administering drops (Newman-Casey et al., 2019).  
42 
 
Numerous studies in the United States and other countries have shown poor 
technique to be a considerable concern in nonadherence (Newman-Casey, Robin, et al., 
2015). Newman-Casey, Robin, et al. (2015) identified that worsening glaucoma is 
associated with changes in visual function, but these occur gradually, often without 
patients’ awareness. The only way to truly discern if the glaucoma is under control is 
through a series of follow-up appointments where the ophthalmologist can compare 
subsequent test results to the baseline and keep checking the stability of the intraocular 
eye pressure (Konstas et al., 2018). However, these visits might be as frequent as every 
few months, with a considerable wait time. Konstas et al.’s (2018) findings indicated that 
infrequency could further contribute to nonadherence, as patients might not understand 
the value of these visits.  
Frequently, patients may need more than one medication regimen. Ocular surface 
disease is extremely common in glaucoma patients and a significant cause of 
comorbidity, requiring more than one medication treatment (Zhang et al., 2019). In these 
situations, nonadherence is related to patients receiving multiple medications. 
Researchers found that persistence declined as the number of medications increased, and 
compliance with medications faltered due to side effects and a lack of symptoms 
secondary to glaucoma itself (Weinreb et al., 2018; Zhang et al., 2019). Many patients are 
unconcerned about worsening glaucoma because of the lack of symptoms, whereas others 
might become fatalistic, give up, and stop taking their medication (Colombo et al., 2016). 
Both apathetic and fatalistic perceptions regarding the possibility of worsening glaucoma 
could cause insufficient motivation to adhere to treatment regimens. 
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Approaches to Improve Adherence and Persistence 
Increasing the proportion of people who adhere to glaucoma therapy could help 
delay disease progression as well as subsequent vision loss and reduced quality of life. 
Researchers have conducted studies to address health-promoting interventions that might 
improve adherence to glaucoma treatment (Wolfram et al., 2019). Some of these 
interventions include educational and instructional videos about glaucoma and ocular 
medication instillation, eye drop administration trackers, automatic medication refills sent 
to the pharmacy, telephone calls and texts to remind patients to take their drops, and 
counseling sessions with motivational interviewing and behavioral modification 
techniques (Newman-Casey, Robin, et al., 2015). Many of these interventions had a 
substantial impact on improving medication adherence in the short term (Slota et al., 
2015). Telephone counseling proved to be not as effective as counseling offered in 
person; however, few medical offices were equipped to offer in-person counseling. 
Moreover, interventions with adequate time to spend with the patients to address each 
person’s needs were difficult and not sustainable for busy ophthalmological practices. To 
date, no standardized approaches to improving support for glaucoma patient self-
management and developing health-promoting behavior have emerged (Fudemberg, Lee, 
et al., 2016; Slota et al., 2015; Wolfram et al., 2019).  
For an intervention to be successful and sustainable, patients’ perceived severity 
of the disease and benefits of treatment must be higher than their experiential lack of 
symptoms and bothersome medication side effects (Killeen et al., 2020; Wolfram et al., 
2019). Time spent educating patients should include a few key factors. The patient must 
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understand that glaucoma causes vision loss, the treatments offered by their doctor could 
mitigate this effect, and the barriers to following their physician’s recommendation are 
not difficult to overcome and outweigh the perceived benefit of treatment (Davis et al., 
2019). However, patient education becomes a time-consuming process for which current 
ophthalmology practices are not equipped. Additionally, physicians and staff do not have 
the time or resources to accommodate this level of involved patient care, creating a 
clinical void in the health care service delivery.  
Challenges of Health Care Delivery in Nonacculturated Russian Immigrant 
Communities 
Rates of international migration have reached unprecedented levels in the United 
States and worldwide. The United States has experienced a massive immigration wave, 
its largest in the19th and early 20th centuries, with New York facing a rapidly changing 
demographic landscape and an increasingly multiracial and multicultural population 
(New York City Department of Health and Mental Hygiene [NYC Health], 2020). New 
York, has a dense immigrant residential population stratified by pockets of residential 
nonacculturation. Acculturation happens when groups of individuals from different 
cultures come into continuous, firsthand contact, resulting in the assimilation of one 
group into the other. Eastern European Russian immigrants 65 years and older become 
Medicaid and social assistance beneficiaries with opportunities for subsidized housing, 
which inadvertently stratifies immigrant populations, creating dense, insular pockets with 
no need to acculturate. Such homogeneous and concentrated cultural pockets could 
appear at sub-zip code levels in neighborhoods throughout the borough. Additionally, 
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homogeneous neighborhood composition creates enclaves of living and drives the need to 
create service delivery in culturally adherent standards (NYC Health, 2020). For instance, 
the area once known as Brighton Beach has received the moniker “Russian Beach” due to 
most of its residents being Eastern European Russian immigrants.  
Language presents a challenge in serving this community, as the majority of the 
population’s service area speaks primarily Russian (NYC Health, 2020). Insular 
neighborhoods resistant to acculturation face challenges and barriers to health care, such 
as linguistic incompatibilities, insurance eligibility, familiarity with the U.S. health care 
system, and the ability to connect with and understand non-Russian care providers (Kim 
et al., 2015; NYC Health, 2020).  
Older immigrant populations already experience adaptation challenges because of 
cultural gaps between their values and those of the host society (Kim et al., 2015). Such 
experiences also result in a lack of social support from the host society, family conflicts, 
and racial discrimination. Individuals strive to maintain their cultural heritage and 
cultural identities, subsequently leading to low acculturation. Although prior research 
shows that advanced cultural connectedness, community strength, and participation help 
older immigrants gain a sense of social, cultural, and psychological significance, it 
inadvertently promotes nonacculturation (Kim et al., 2015; Wright-St. Clair et al., 2018), 
directly affecting health care delivery.  
Older Russian immigrants experience difficulty seeking medical help from non-
Russian-speaking providers due to language barriers and cultural misunderstandings. 
Access to high-quality eye and vision care is a component of a comprehensive population 
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health approach to reduce vision impairment (Lee, 2017; McKeever et al., 2019). The 
present health care landscape offers health care services from Russian providers; 
however, few are ophthalmologists, and even fewer are glaucoma specialty providers. In 
addition to the lack of Russian-speaking glaucoma ophthalmology providers, conflicting 
clinical practice guidelines create different standards, leading to confusion regarding 
what care is needed and when. Limited integration among and between clinical public 
health series combined with insufficient cross-disciplinary training of the workforce 
negatively affects the diagnosis and follow-up care. Additional population distrust toward 
non-Russian-speaking providers hampers the ability to improve care quality by applying 
continuous quality improvement programs. 
Filling the Gap in Glaucoma Care Delivery 
Health care provision disparities occur when beneficial medical interventions are 
not shared equally and arise from a complex interplay of economic, social, and cultural 
factors (Thornton et al., 2016). Principal causes of such health disparities stem from 
overlapping poverty, culture, and social injustice. These causal factors impact all aspects 
of the health care continuum, from prevention, detection, diagnosis, treatment, and 
survival to the end of life. Disparities occur principally in individuals or populations who 
experience insufficient resources, culturally influenced behavior, and/or social inequities. 
Any successful intervention must entail considering related population characteristics and 
sociocultural environments of proposed service delivery; otherwise, even the most 
efficacious interventions cannot achieve desirable outcomes (Dye et al., 2019; Thornton 
et al., 2016). Such considerations are not easy, as they might challenge the use of 
47 
 
traditional or mainstream interpretations of standard evaluation techniques because of the 
implications of being a socially disadvantaged population (Dye et al., 2019). 
Preventing vision loss and treating vision disorders begins with understanding 
gaps in eye care delivery, especially for older Russian immigrant adults at high risk for 
vision loss (Lee, 2017; McKeever et al., 2019). Demographic shifts in the U.S. 
population alter the prevalence of various conditions associated with vision loss because 
these conditions vary by race, culture, and ethnicity. Prior scholars have not demonstrated 
long-term adherence to glaucoma therapy in diverse populations, although short-term 
educational strategies have been successful (Newman-Casey et al., 2020). Successful 
educational interventions require time for demonstration and conversation, ocular drop 
instillation presentation and practice, and medication side effect discussion. When 
delivered in culturally competent ways and in the patients’ preferred language, the 
interventions are most effective (Dye et al., 2019). Due to a substantial lack of 
specialized Russian-speaking glaucoma providers, office space limitations, no dedicated 
professional specialty to provide such service, asymptomatic nature of glaucoma, long 
waiting times to see the ophthalmologist, and a plethora of side effects associated with 
ocular medications, patients continue to be nonadherent to their glaucoma treatments.  
Professional Service Gap 
The field of ophthalmology is unique in its lack of hiring nurses. Although there 
is a positive correlation between nurse competency and patient care quality, the visibility 
of this career path is not yet widely accepted (Abid et al., 2018; Aw & Dury, 2016; 
Moradi, 2016). The eye care field consists of ophthalmologists who are medical doctors 
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who diagnose, prescribe, and operate and optometrists who specialize in some diagnosis 
and treatment but mostly refractive disorders (Cicinelli et al., 2020; Shamanna et al., 
2005). Opticians fit and make glasses; ophthalmic technicians perform intakes, triages, 
and work up patients; ophthalmic photographers take various images of patents’ eyes and 
perform scans and visual fields (Cicinelli et al., 2020; Shamanna et al., 2005).  
Educating patients about their ocular conditions has long been the provider’s 
responsibility (Rosdahl et al., 2014; Williams et al., 2016). In a survey of patients’ 
preferences in receiving diagnosis and care instructions, Rosdahl et al. (2014) found that 
55% of respondents preferred one-on-one educational sessions from their eye care 
providers. However, for various reasons, ophthalmologists are no longer able to fulfill 
that role. Another consideration was ophthalmic nursing. Although ophthalmology is a 
subspecialty in a nursing curriculum, there is little room for ophthalmic nurses in clinical 
settings. They usually prefer the highly clinical interactions less available in ophthalmic 
settings (Moradi, 2016). Additionally, there has been no evaluation of the cost-
effectiveness of the registered nurse position. Historically, patient navigators are useful to 
improve outcomes in vulnerable populations by eliminating barriers to timely diagnosis 
and treatment of cancer and other chronic diseases (Pratt-Chapman, 2016).  
Patient Navigators 
The first patient navigation program was in 1990 in Harlem, New York, created 
by the president and founder of the Harold P. Freeman Patient Navigation Institute 
(Freeman, 2006; Freeman et al., 1995; Freeman & Rodriguez, 2011). The program’s 
original goal was to reduce cancer mortality by eliminating financial, communication, 
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medical system, psychological, and logistical barriers to screening, diagnosis, treatment, 
and supportive care (Freeman, 2006; Freeman & Rodriguez, 2011; Valaitis et al., 2017). 
The scope of patient navigation has evolved to become a patient‐centric health care 
service delivery intervention with the principal purpose of eliminating barriers occurring 
across the health care continuum (Valaitis et al., 2017). This program has expanded to 
application across the health care continuum to help patients with chronic diseases other 
than cancer in such areas as prevention, detection, diagnosis, treatment, education, 
supportive care, and end-of-life care. 
In recent years, most navigation programs have been means to help patients 
overcome barriers to care, such as challenges with health literacy or fluency in the 
English language affecting comprehension of diagnosis and treatment, lack of 
transportation, or insufficient insurance coverage (Ko et al., 2019). Patient navigators 
have also strived to build and strengthen the communications and relationships between 
patients and health care professionals while addressing psychosocial concerns of patients 
and their families (Ko et al., 2019; Lopez et al., 2019). Another common role of 
navigators has been to close the gaps in the health care system by tracking patient care 
and ensuring smooth handoffs from one provider to another (Kline et al., 2019; Ko et al., 
2019). Many interventions have been in predominantly minority and economically 
underserved areas, often in urban cancer centers (Lopez et al., 2019).  
Inadequate communication between clinician and patient is a common contributor 
to chronic health care problems. Patient navigators can address these concerns, which are 
often due to a patient’s lack of fluency in English, health literacy, or self-efficacy or to 
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clinician insensitivity. (Kline et al., 2019; Lopez et al., 2019). Wells et al. (2018) 
conducted a nationwide cross-sectional study to assess the roles of patient navigators, 
successful patient navigator characteristics, and work settings. In community-based 
organizations and chronic health care offices, navigators frequently made arrangements 
and referrals to services, provided care coordination and education, and assisted with 
obtaining basic needs and addressing the barriers preventing patients from obtaining 
health care (Wells et al., 2018). Pratt-Chapman et al. (2015) found that a clinical degree 
is not necessary for a successful patient navigator; instead, the most important 
qualification was being a “cultural broker and interpreter” from the serviced 
communities. Additionally, patient navigators with certain personal qualities, such as 
being personable and willing to improve the lives of others, have the greatest success 
with patient treatment compliance (Duggleby et al., 2016; McMullen et al., 2016; 
Ustjanauskas et al., 2016). Wells et al. identified the clinical specialties that used patient 
navigators, including oncology, diabetes, cardiovascular disease, asthma, chronic 
obstructive pulmonary disease, and HIV/AIDS. Most of these conditions are chronic, like 
glaucoma.  
There has been little evaluation of patient navigators’ effectiveness in 
ophthalmological settings. Newman-Casey, Blachley, et al. (2015) evaluated the 
effectiveness of nonphysician presurgical counselors teaching patients about cataracts 
and cataract surgery in improving patient knowledge, decisional conflict, and patient 
satisfaction outcomes. Findings indicated that increased use of high-quality counseling 
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might reduce decisional conflict about cataract surgery among patients with more limited 
access to health care. 
Although not a patient navigator program, Newman-Casey, Blachley, et al.’s 
(2015) research was close to a concept study regarding surgical interventions. Hark, 
Johnson, et al. (2016) evaluated whether the use of a patient navigator altered adherence 
to follow-up eye care appointments in community-based versus office-based settings. 
Findings from their study showed that help from a patient navigator did not increase the 
long-term likelihood of keeping follow-up appointments in an office-based setting. One 
limitation of this study was the recruitment of subjects from a prior glaucoma study, the 
findings of which showed patient familiarity with the research staff, which likely 
increased appointment adherence across all groups. Last, the participants were self-
selected and might not reflect the general patient population.  
Reasons Providing Education Has Not Worked in Prior Research 
Nonadherence to medical treatment is a problem that has gained enormous 
attention. Researchers have conducted extensive studies to identify the cause of the 
problem and solutions for nonadherence. Some evidence has shown that educating 
patients on glaucoma management may improve medication adherence (Rao et al., 2016). 
Of eight studies that focused on improving patient knowledge to increase adherence to 
glaucoma medications, Newman-Casey, Dayno, et al. (2016) found that five showed 
significant short-term improvements in adherence after educational interventions, two 
showed nonsignificant improvements, and one showed no improvement in patients who 
had relatively high baseline knowledge of glaucoma. Because the studies used vastly 
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different interventions, it was difficult to determine which aspects of each educational 
intervention had the most significant impact on medication adherence (Robin & Muir, 
2019). According to Newman-Casey, Dayno, et al., respondents reported various 
difficulties administering eye drops, including aim (24%); controlling the number of 
drops dispensed (18%); holding steady while squeezing the bottle (10%); flinching or 
blinking, causing the drops not to enter the eye (10%); and squeezing the bottle (5%). 
Although providing patient education could theoretically remedy all these difficulties, the 
researchers asserted that many studies had not supported these results in the long term. 
Educational interventions have shown some significant improvement short term; 
however, this might be due to the Hawthorne effect. 
The Hawthorne effect refers to research participants altering their behavior based 
on the awareness of being observed and participating in the trial (Parsons, 1974). 
Therefore, the Hawthorne effect could significantly affect the generalizability of clinical 
research findings. Parsons (1974) described the Hawthorne effect from a study in which 
subjects’ response rates rose without manipulating the IVs. This study created an interest 
in confounding variables because of some aspect of the experiment itself, such as subject 
observation. Goodwin et al. (2017) examined the degree to which the Hawthorne effect 
altered outpatient visit content. Although an observer’s presence had little effect on most 
patient‐physician visits, it appeared to affect a subgroup of vulnerable patients. Because 
most participants in prior studies about glaucoma interventions were lower-income, 
minority, and vulnerable populations, it is possible to assume that some part of short-term 
behavior change could be due to the Hawthorne effect. 
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Summary and Conclusion 
POAG leads to progressive damage to the optic nerve and is the leading cause of 
irreversible blindness worldwide (Abdull et al., 2016). Blindness from glaucoma is 
avoidable with early diagnosis and appropriate, sustained, life-long treatment (Abdull et 
al., 2016; Kyari et al., 2016). With adequate knowledge, adherence to follow-up care, and 
proper ocular medication utilization, patients can prevent blindness from this disease. 
However, studies have shown that many patients fail to adhere to treatment 
recommendations and end up losing most of their vision (Nowak & Smigielski, 2015). 
Measuring adherence to medical and behavioral interventions is important to clinicians 
and researchers, as inadequate adherence can reduce an intervention’s effectiveness.  
In this quantitative study, I explored the effects of education about glaucoma 
provided by a patient navigator on patients’ knowledge about glaucoma, adherence to 
follow-up visits, and ocular medication utilization. A private glaucoma clinic in New 
York gathered data for its internal cost-benefit analysis of hiring and training a patient 
navigator.  
In Chapter 3, I describe the research method, purpose of study, research design, 
and rationale. I discuss the target population, sample and sampling procedure, and 
procedure used for the collection of and access to archived data. Finally, Chapter 3 
presents the instrumentation and operationalization of constructs, ethical procedures, and 
threats to internal, external, and statistical validity.  
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Chapter 3: Research Method 
The purpose of this study was to determine whether education about glaucoma 
provided by a patient navigator affected patient knowledge about glaucoma, patient 
adherence to follow-up visits, and medication utilization among Russian Eastern 
European immigrant patients at a private glaucoma clinic in New York. This study 
entailed the use of archival data with a longitudinal design. In this chapter, I describe the 
research design and rationale, define the IV and DVs, and identify the research design 
and its relevance to the study. Chapter 3 presents the target population, sampling, sample 
size, procedure used for collecting archival data, and data analysis using Statistical 
Package for the Social Sciences (SPSS). Finally, I identify resource constraints associated 
with the research design and describe how this design is consistent with the approach 
needed to advance knowledge in the field.  
Research Design and Rationale 
In this quantitative study, I attempted to identify whether there was an effect of 
education about glaucoma provided by a patient navigator on patient knowledge about 
glaucoma, patient adherence to follow-up visits, and ocular medication utilization. A 
private glaucoma clinic in New York gathered data to analyze the costs and benefits of 
hiring and training a patient navigator. The clinic provided the information to me in an 
Excel spreadsheet. From the archival data, I examined patient answers collected at three 
time points, making this a longitudinal retrospective study design. The IV was exposure 
to education about glaucoma through a patient navigator, and the DVs were patient 
55 
 
knowledge of glaucoma, patient adherence to follow-up visits, and patient utilization of 
prescribed ocular medications.  
Longitudinal cohort studies are appropriate to evaluate education or other medical 
research interventions because the design allows the researcher to follow change over 
time among particular individuals within the cohort (Caruana et al., 2015). The 
longitudinal cohort study design enables researchers to establish a sequence of events to 
identify and relate events to a particular exposure. I sought to evaluate whether exposure 
to education impacts patient outcomes, making the longitudinal cohort design the most 
appropriate for this study. Disadvantages of longitudinal cohort studies include 
incomplete or interrupted follow-up of individuals and attrition over time, and an 
inability to control individual exposure to an occurrence, both of which might affect the 
outcome (Caruana et al., 2015).  
Research Questions and Hypotheses 
This quantitative study was a means to explore whether exposure to education 
about glaucoma provided by a patient navigator impacts patient knowledge about 
glaucoma, patient adherence to follow-up visits, and ocular medication utilization. The 
RQs and their corresponding hypotheses for this study were as follows: 
RQ1: Are there significant differences between pretest and posttest in knowledge 
of glaucoma as a function of whether patients are provided with additional education? 
H01: There are no significant differences between pretest and posttest in 
knowledge of glaucoma. 
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Ha1: There are significant differences between pretest and posttest in knowledge 
of glaucoma. 
RQ2: Are there significant differences between the two groups in knowledge of 
glaucoma as a function of whether patients are provided with additional education?  
H02: There are no significant differences between the two groups in knowledge of 
glaucoma. 
Ha2: There are significant differences between the two groups in knowledge of 
glaucoma. 
RQ3: Is there an interaction effect between time and group in knowledge of 
glaucoma as a function of whether patients are provided with additional education?  
H03: There is no interaction effect between the time and group in knowledge of 
glaucoma. 
Ha3: There is an interaction effect between the time and group in knowledge of 
glaucoma. 
RQ4: Is patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up appointment at T3 dependent on whether patients were exposed to education 
about glaucoma? 
H04: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up appointment at T3 is not dependent on whether patients were exposed to 
education about glaucoma. 
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Ha4: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up treatment at T3 is dependent on whether patients were exposed to education 
about glaucoma. 
RQ5: Is patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 
medication at T3 dependent on whether patients were exposed to education about 
glaucoma? 
H05: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 
medication at T3 is not dependent on whether patients were exposed to education about 
glaucoma. 
Ha5: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 




Participants were individuals of Russian Eastern European immigrant background 
residing in New York newly diagnosed with glaucoma. Archival data underwent 
examination. Excluded from the study were individuals previously diagnosed with 
glaucoma or knowing that they had glaucoma yet had not received treatment. This 
exclusion was necessary to reduce sample contamination and evaluate the education 
provided by the patient navigator.  
58 
 
Procedures for Recruitment and Participation 
Data collection was by a private glaucoma clinic in New York serving the largest 
Russian Eastern European immigrant population. A glaucoma specialist ophthalmologist 
owns and operates the practice, seeing between 80 and 100 patients daily. Due to the 
underserved nature of that area, there is a 3-month waiting list for new patients. The 
practice owner performed a cost-benefit analysis of hiring and training a patient navigator 
to provide education to patients and increase patient screening efficiency. The practice 
collected the data during regular patient visits and new patient consultations. Using the 
GKI, the patient navigator administered the educational portion of the exam in Group 2 
and collected the data from both groups at T1, T2, and T3 (Celebi, 2018). After the index 
administration, the patient navigator ensured good data quality by comparing the 
responses to the medical records.  
The glaucoma clinic provided a Data Use Agreement (see Appendix), allowing 
me access to the archival dataset gathered at the facility. From this archival demographic 
data, I based respondent selection on the following study inclusion criteria: (a) Russian 
immigrant or of that descent, (b) age 45 to 80 years, (c) no known or diagnosed cognitive 
impairment, and (d) not previously diagnosed with glaucoma. I extracted eligible 
participant data from the spreadsheet, using SPSS to determine statistically significant 
findings between the variables.  
Data Collection 
A private glaucoma clinic in New York employed and trained a patient navigator 
to provide education to individuals diagnosed with glaucoma, and subsequently 
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conducted a cost-benefit analysis of hiring such an individual. The data collection was 
also part of the practice’s efforts to improve engagement and quality of care for its 
patients. The practice administrator used a random number generator from 
RANDOM.org to split the patients into two groups. Patients assigned to Group 1 
underwent a standard eye exam and received a diagnosis of glaucoma and education from 
a physician about their condition. Group 2 received the same exam and diagnosis as 
Group 1 with additional education from a patient navigator, visual representation through 
an eye model, materials in their native Russian language, and an involved demonstration 
of eye drop instillation. The patient navigator spent 20 to 30 extra minutes with the 
patient, allowing time for a discussion and questions. The patients were to return in 1 
month for a mandatory follow-up appointment, which the clinic documented. Patients 
assigned to both groups answered a GKI at three times: prior to the eye exam (T1), right 
after the eye exam for Group 1 and eye exam and educational workshop for Group 2 
(T2), and at their 1-month follow-up appointment (T3). The clinic sexported and 
provided the data to me into Microsoft Excel.  
To avoid role confusion and evaluate the cost-benefit analysis of the patient 
navigator, it was necessary to specify roles. After signing in for their visit, a practice 
assistant escorted Group 1 patients into a screening room and administered the GKI 
questionnaire (T1), with responses collected via pen and paper. The patients then 
received the usual workup consisting of chief complaint, medication verification, and 
best corrected visual acuity measure. The ophthalmologist then met with the patients to 
conduct a standard slit lamp exam and pressure check and discuss the findings. The 
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ophthalmologist presented the ocular medications and requested a follow-up appointment 
in 1 month to ensure the drops controlled the pressure. This prescreening and the exam 
took approximately 15 minutes. At the conclusion of this exam, the practice assistant 
administered the GKI (T2). The patient then scheduled a 1-month follow-up appointment 
with the front desk receptionist. At the follow-up appointment, the practice assistant 
administered the GKI during the screening (T3) prior to the medical exam by the 
ophthalmologist. If patients missed their follow-up exam, the clinic made one 
rescheduling attempt. If the attempt was unsuccessful or the patient did not show up to 
the rescheduled appointment, I treated the participant’s information as missing data.  
Patients assigned to Group 2 received the same care as those in Group 1. 
However, after the ophthalmologist exam, Group 2 patients went into the patient 
navigator’s office, where they received education about their diagnosis with the aid of a 
visual model of the eye. The patient navigator also provided a handout describing 
glaucoma and what occurs without following proper treatment. The patient navigator also 
demonstrated the proper instillation of ocular drops and had the patient practice with the 
eye model. The take-home materials were available in English and in Russian. After the 
exam, the patient navigator escorted the patient to the front desk to schedule a 1-month 
follow-up appointment. Prior to the patient leaving the practice, the assistant 
administered the GKI (T2). At the 1-month follow-up appointment, the practice assistant 
administered the GKI during the screening (T3), prior to the medical exam by the 
ophthalmologist. For patients who missed their follow-up exam, there was one attempt at 
rescheduling the appointment, at which time (T3) they completed the questionnaire. If the 
61 
 
office could not reach the patient or the patient did not attend the rescheduled 
appointment, the participant’s responses had missing data and were not entered into the 
calculations. 
Sampling and Sampling Procedure  
The data set came from a private glaucoma clinic in New York. I conducted a 
G*Power analysis to calculate the minimum sample size required to detect an effect. To 
detect a medium effect size of partial eta-squared of 0.1 with 80% power, an industry-
recommended minimum for between-subjects repeated measures, the G*Power analysis 
showed a need for 82 participants in each group for a total sample size of 164. This was a 
calculation for ANOVA, with equal sample sizes for each group (see Bakeman, 2005; 
Lakens, 2013). To account for an estimated 25% attrition from T1/T2 for the data 
gathered on the same day as T3, collected at the 1-month follow-up appointment, I used 
data from 206 participants at T1/T2 (103 from Group 1 and 103 from Group 2). Results 




Results From Power Analysis 
 
Note. Minimum sample size. 
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Instrumentation and Operationalization of Constructs  
Celebi (2018) developed the GKI to assess patients’ knowledge about glaucoma. 
Celebi used the GKI in a research hospital in Istanbul, Turkey, to assess knowledge and 
awareness of glaucoma in subjects with glaucoma and their first-degree relatives. 
Because the GKI is an index of knowledge, reliability is irrelevant; therefore, there was 
no need to compute a Cronbach’s alpha (see Bland & Altman, 2002). The scale for this 
design was across nine questions in the analysis, including an aggregate of true-false and 
multiple-choice answers. I created a total score of knowledge, reporting the means and 
standard deviation after data analysis.  
The IV in this study was education about glaucoma provided by a patient 
navigator. The IV was a dichotomous variable with two levels: two groups of patients. 
Patients in Group 1 received usual and standard care provided by an ophthalmologist 
during an initial visit; Group 2 patients received the same care as Group 1 with additional 
education provided by a patient navigator. After the patients’ standard visit and a 
discussion with an ophthalmologist, the patient navigator spent 20 to 30 minutes 
providing education about glaucoma through a visual representation of an eye model and 
take-home materials in their native Russian language. In addition, the patient navigator 
conducted an involved demonstration of proper eye drop instillation. Changes in 
knowledge about glaucoma, one of the DVs, was the construct I examined in this study. 
Operationalizing knowledge changes was by participants’ responses to the GKI, a nine-
item index with each question worth 1 point. The questions were means to determine 
whether the individuals had knowledge and understanding of glaucoma, its predisposing 
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factors, and treatment. Determining patients’ understanding and knowledge about 
glaucoma was by calculating the number of points scored by the individual on the GKI, 
with the scores ranging from 0 to 9. For this study, individuals having a high level of 
knowledge and understanding about glaucoma (e.g., GKI scores of 8 or 9) were 
considered knowledgeable about glaucoma; individuals with low levels of adherence 
(GKI scores of 7 or lower) were considered not knowledgeable. I considered changes in 
knowledge about glaucoma as a function of time.  
The next DV was adherence to follow-up care, a dichotomous variable measured 
by whether patients attended their scheduled follow-up appointments. Another DV was 
adherence to ocular medication utilization, which was also a dichotomous variable 
measured by whether patients used their prescribed ocular medications. Measurement of 
this variable was by patient self-report.  
Data Analysis Plan 
I used SPSS to process and analyze the quantitative data. This program also 
allowed data cleaning and screening. Data processing techniques consisted of identifying 
potential outliers and testing the assumptions of each statistical analysis. 
The first three research questions (RQ1, RQ2, and RQ3) required examining the 
extent to which patients’ exposure to education about glaucoma through a patient 
navigator impacted their knowledge about glaucoma, as measured before and after the 
eye exam. The glaucoma education provided by the patient navigator was the IV, and the 
patients’ knowledge of glaucoma was the DV. The IV had two categories: group 
membership (i.e., whether the participants were in Group 1 or Group 2) and time of 
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assessment (i.e., T1, T2, or T3). The DV, a continuous measure, was the knowledge 
about glaucoma. The statistical analysis used to answer this research question was a 
repeated measures ANOVA.  
The DV was continuous to determine variability, giving it prediction power. I was 
looking for three effects: within subjects (pretest vs. posttest scores), between subjects 
(Group 1 vs. Group 2), and whether there was an interaction effect. If the interaction 
effect was significant, the main effects of time and grouping required investigation. An 
interaction between the two IVs provides an understanding of whether knowledge 
changes over time differently depending on group membership.  
One assumption for a repeated measures ANOVA is normality, with the DV and 
within-subjects IV normally distributed. Violating this assumption allows for the use of 
transformation. Another assumption was sphericity, where the variance of the difference 
scores for any two levels of the within-subjects IV was similar to the variance of the 
difference scores for any other two levels of the within-subjects IV. Mauchly’s test of 
sphericity was a means to test this assumption, with a violation meriting the use of p < 
.05 and the Greenhouse-Geisser or Huynh-Feldt corrections. Another assumption was 
that of homogeneity of variance, where the standard deviation of the DV should be equal 
between the two groups. Testing the equality of variances entailed performing Levene’s 
test. If p < .05, the Welch-Satterthwaite method is a way to make adjustments based on 
the degrees of freedom.  
RQ4 pertained to how exposure to education about glaucoma predicts patients’ 
adherence to follow-up treatment at T3. The IV, group membership, underwent analysis 
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as a categorical variable with two levels, Group 1 and Group 2. The DV, whether patients 
showed up to the T3 appointment, was a categorical variable analyzed as a follow-up 
appointment attended or missed. Because of the categorical nature of the IV and DV, a 
chi-square test of independence was appropriate.  
The fifth research question (RQ5) was specific to how exposure to education 
about glaucoma predicts patients’ adherence to the use of prescribed ocular medications. 
The IV was group membership (Group 1 vs. Group 2), with the study groups independent 
and analyzed as a categorical variable with two levels. The DV, whether they used their 
prescribed ocular medications as instructed by the physician, was also a categorical 
variable analyzed as medication used or not used.  
The chi-square test of independence was appropriate to address the fourth and 
fifth research questions because it is a nonparametric test designed to analyze whether 
there is a significant relationship between two categorical variables (McHugh, 2013; 
Montgomery, 2013). This statistical analysis was suitable because group status and the 
DVs (attendance at the follow-up and taking medication) are dichotomous variables. The 
chi-square test is nonparametic and does not assume a normal distribution, making it 
appropriate for dichotomous variables. The statistical analysis was a means to test for the 
relationship of group status to follow-up attendance by examining whether the 
distribution of yes and no in Group 1 matched the distribution of yes and no in Group 2. 
This kind of analysis was limited to variables in which both levels were mutually 
independent, such that no participant fell into both Group 1 and Group 2. The chi-square 
test allows for examining data at a single time point only rather than in a longitudinal 
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fashion (McHugh, 2013). Additionally, the chi-square test is sensitive to sample size. 
This statistical analysis is appropriate to determine whether a relationship exists between 
two variables; it cannot test for a causal effect from one variable to the other (McHugh, 
2013). 
Threats to Validity 
Threats to Internal Validity  
Potential threats to internal validity included whether there was enough variation 
in the DV and the ability to index the degree of difference among people’s glaucoma 
knowledge. Another threat to internal validity could have been having more patients than 
normal attend their follow-up visit (T3) due to the severity of their glaucoma symptoms, 
something not assessed. Last, prior to agreeing to participate in the study, patients learned 
that if assigned to Group 2, they might have to spend up to an extra 30 minutes with a 
patient navigator. If patients opted not to participate due to the requirement of extra time, 
there could be a difference in conscientiousness between the groups, which could have 
been an unstudied third variable.  
Threats to External Validity  
One threat to external validity was the lack of transferability. The population 
assessed was Russian Eastern European immigrants in New York. Because the results 
apply to a narrow population and a specific situation, the findings might have poor 
generalizability. Another potential threat to external validity was selection bias. Because 
patients self-selected to participate in this study, there could have been volunteer bias, 
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with individuals who volunteer to participate in a research project different in some ways 
from the general population. 
Ethical Procedures 
Agreement to Gain Access to Data  
A private glaucoma clinic located in New York provided a Data Use Agreement 
(see Appendix), allowing me access to the archival data collected at its facility. The 
practice deidentified the archived data before it was available. Upon receipt of the Excel 
file, I extracted information relevant to the study. Subsequently, I coded data to eliminate 
patient identifiers and limit the risk of exposure. I did not receive or analyze data until 
receiving written approval from Walden University’s Institutional Review Board (IRB; 
Approval No. 08-31-20-0725508).  
Treatment of Archival Data  
The archived data remain safeguarded to prevent unwanted access. I was ethically 
obligated to ensure that the use of data and dissemination of findings would not harm the 
system that provided the data or to the people who accessed the health care system. 
Therefore, the use of archived data was solely for this study. The data obtained are not 
available to any other person or organization. I did not need to obtain patients’ informed 
consent, as I analyzed only archival data. No treatment or invasive tests occurred during 
or for this study. I will maintain the deidentified archival data on a password-protected 




Chapter 3 presented the study design, sample characteristics and sampling 
methods, instrumentation, data analysis, and ethical procedures. Data collection was by a 
private glaucoma clinic in New York, which provided a Data Use Agreement. Upon 
obtaining IRB approval, I conducted a longitudinal retrospective study using the obtained 




Chapter 4: Results 
The purpose of this study was to explore whether additional education about 
glaucoma has an effect on patient knowledge of glaucoma, patient adherence to ocular 
medication use, and follow-up appointment attendance. The general question that guided 
this research was the following: Does the independent variable (exposure to education 
about glaucoma through a patient navigator) have an effect on patient knowledge of 
glaucoma, patient adherence to follow-up visits, and patient utilization of prescribed 
ocular medications among patients newly diagnosed with glaucoma among the Russian 
Eastern European immigrant population in a private glaucoma specialty clinic in New 
York? I investigated this general question through five specific RQs: 
RQ1: Are there significant differences between pretest and posttest in knowledge 
of glaucoma as a function of whether patients are provided with additional education? 
H01: There are no significant differences between pretest and posttest in 
knowledge of glaucoma. 
Ha1: There are significant differences between pretest and posttest in knowledge 
of glaucoma. 
RQ2: Are there significant differences between the two groups in knowledge of 
glaucoma as a function of whether patients are provided with additional education?  
H02: There are no significant differences between the two groups in knowledge of 
glaucoma. 




RQ3: Is there an interaction effect between time and group in knowledge of 
glaucoma as a function of whether patients are provided with additional education?  
H03: There is no interaction effect between the time and group in knowledge of 
glaucoma. 
Ha3: There is an interaction effect between the time and group in knowledge of 
glaucoma. 
RQ4: Is patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up appointment at T3 dependent on whether patients were exposed to education 
about glaucoma? 
H04: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up appointment at T3 is not dependent on whether patients were exposed to 
education about glaucoma. 
Ha4: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up treatment at T3 is dependent on whether patients were exposed to education 
about glaucoma. 
RQ5: Is patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 
medication at T3 dependent on whether patients were exposed to education about 
glaucoma? 
H05: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 




Ha5: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 
medication at T3 is dependent on whether patients were exposed to education about 
glaucoma. 
In this chapter, I present the collected archived data and include information 
regarding the procedures for gathering the patients’ information. Analysis of data to 
answer the first three RQs (examining the extent to which patients’ exposure to education 
about glaucoma through a patient navigator impacts their knowledge about glaucoma) 
entailed using a repeated measures ANOVA. Answering the fourth and fifth RQs entailed 
conducting a chi-square test of independence. 
Data Collection 
I obtained the study data from a private glaucoma clinic located in Kings County 
of New York, which had conducted a cost-benefit analysis for hiring a patient navigator. 
The data collection was also part of the practice’s efforts to improve the engagement and 
quality of care for the patients. The clinic administered the GKI (Celebi, 2018) to 206 
patients at three time points (T1, T2, and T3) between December 2018 and December 
2019. The patient navigator was responsible for administering the GKI and providing 
education to Group 2 patients. The clinic had adequately trained and certified the patient 
navigator before assigning them to the patients. The patient navigator had been an 
ophthalmic technician for 17 years before transitioning to the role. The patient navigator 
was a native Russian speaker able to communicate with patients in either English or 




Preparing Data for Analysis  
Data cleaning is a significant component of preparing data for analysis. Upon 
receipt of the archival data in an Excel spreadsheet, I recoded the numerical answers for 
the 11 questions. Some questions were multiple choice and allowed for more than one 
answer; some of the answers given included correct and incorrect responses. For this 
analysis, if a patient had selected both a correct and an incorrect answer choice, I counted 
the response as correct, giving the participant full credit. Recoded responses for 
Questions 3 through 11 were 0 = incorrect and 1 = correct. Questions 1 and 2 remained 
the same because they were part of demographic knowledge gathering. After removing 
all personal identifiers from the data set, I converted the Excel spreadsheet into an SPSS 
data file to record responses in a numerical format.  
Descriptive Statistics 
The IV for this study was whether participants received education about glaucoma 
from a patient navigator. The DVs included patient knowledge about glaucoma, 
attendance of follow-up appointments, and adherence to using prescribed ocular 
medications. Tables 1 and 2 present a summary of the descriptive variables for each 
variable included in the data analysis.  
There were 206 participants evenly split between Group 1 (control; n = 103) and 
Group 2 (intervention; n = 103). Table 1 shows the sample descriptive statistics for the 
categorical variables of attendance of follow-up appointments and adherence to using 
prescribed ocular medications for the entire sample and then separated by group. Of the 
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206 participants, 70.4% attended the follow-up (n = 145). Most of these patients reported 
medication adherence (n = 111; 53.9%), as shown in Table 1. For those in Group 1, 67 
attended the follow-up (65%), of whom 47 adhered to medication (70.1%). In Group 2, 
78 participants attended the follow-up (75.7%), of whom 64 adhered to medication 
(82.1%).  
Table 1 
Frequencies of Demographic Variables 
Variable Entire sample Control Intervention 
 Frequency % Frequency % Frequency % 
Condition       
Control 103 50.0     
Intervention 103 50.0     
Total 206 100.0     
Attend 3 months       
No 61 29.6 36 35.0 25 24.3 
Yes 145 70.4 67 65.0 78 75.7 
Total 206 100.0 103 100.0 103 100.0 
Medication       
Did not adhere 34 23.4 20 29.9 14 17.9 
Adhered 111 76.6 47 70.1 64 82.1 
Total 145 100.0 67 100.0 78 100.0 
 
Table 2 presents descriptive statistics for GKI at all three time points (T1, T2, and 
T3) for the entire sample, and then separated by group. Across the sample, the mean GKI 
score at T1 was 4.28, with a standard deviation of 1.81. The mean GKI score at T2 was 
8.08, with a standard deviation of 2.06; at T3, the mean was 7.63, with a standard 




Descriptives for Continuous GKI at All Three Time Points 
Variable N Min Max Mean Std. 
Dev 
Skew Kurtosis 
      Stat SE Stat SE 
Entire sample          
GKI T1 206 2 9 4.28 1.81 0.71 0.17 -0.06 0.34 
GKI T2 206 2 10 8.08 2.06 -0.84 0.17 -0.32 0.34 
GKI T3 145 2 10 7.63 1.99 -0.60 0.20 -0.49 0.40 
Control          
GKI T1 103 2 9 4.61 1.98 0.55 0.24 -0.46 0.47 
GKI T2 103 2 10 6.60 1.82 -0.16 0.24 -0.19 0.47 
GKI T3 67 2 10 6.22 1.79 0.06 0.29 -0.12 0.58 
Intervention          
GKI T1 103 2 9 3.95 1.57 0.74 0.24 0.20 0.47 
GKI T2 103 4 10 9.56 0.90 -3.64 0.24 17.12 0.47 
GKI T3 78 5 10 8.85 1.20 -1.14 0.27 0.95 0.54 
 
Testing Statistical Assumptions 
Testing the statistical assumptions of the first three RQs was by using a repeated 
measures ANOVA. The first assumption of a repeated measures ANOVA is that DV 
measurement was continuous. Because I measured patient knowledge about glaucoma 
continuously, this assumption was met.  
Examining the second assumption of normality of the DV occurred in three ways. 
First, I performed the Shapiro-Wilk’s test to determine whether glaucoma knowledge was 
normally distributed at all three time points. I found this not to be the case (p < .05), as 
shown in Table 3. Next performed was a visual inspection of the histograms of glaucoma 
knowledge at all three time points (see Figures 3–5). The visual inspection showed that 
the distribution of glaucoma knowledge at T1 and T3 did not indicate a large departure 
from a normal distribution. However, the distribution of glaucoma knowledge at T2 
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showed a heavy amount of skew. Finally, I examined skewness and kurtosis at all three 
time points for the entire sample as well as separated by group, as shown in Table 2. In 
concurrence with the visual inspection, skewness and kurtosis fell within the acceptable 
+/-1 range, except for glaucoma knowledge at T2 for the intervention group. Figure 6 
shows that the extreme level of skewness at T2 for the intervention group was due to 
most of Group 2 reporting high scores on glaucoma knowledge after receiving additional 
education. A square root transformation of each time point was necessary due to the 
extreme nature of skewness at T2. However, using the transformed version of GKI did 
not change the results of the repeated measures ANOVA. I kept the original version of 
the DV at all three time points to ease findings interpretation.  
Testing the final assumption of homogeneity of sphericity was by using 
Mauchly’s test of sphericity to examine whether the variance in glaucoma knowledge 
was equal for all possible pairs. Mauchly’s test indicated a violation of the assumption of 
sphericity for the two-way interaction (χ2(2) = 43.74, p < .001, ε = 0.79). Because the 
estimated epsilon was over 0.75, the Huynh-Feldt correction was necessary to examine 




GKI Pairwise Comparisons Between Time Points 
Variable Mean difference SE p 
GKI T1    
T2 -3.86* 0.14 < .001 
T3 -3.23* 0.14 < .001 
GKI T2    
T1 3.86* 0.14 < .001 
T3 .64* 0.09 < .001 
GKI T3    
T1 3.23* 0.14 < .001 
T2 -.64* 0.09 < .001 
 
Figure 3 





Histogram of GKI at Time 2 for the Entire Sample 
 
Figure 5 












I conducted a repeated measures ANOVA to examine the first three research 
questions. The model had a within-subjects variable of time when the clinic gathered 
glaucoma knowledge (T1, T2, and T3). The between-subjects variable was group, which 
contained two levels: Group 1 and Group 2. The model also incorporated the interaction 
between time and group.  
RQ1: Are there significant differences between pretest and posttest in knowledge 
of glaucoma as a function of whether patients are provided with additional education? 
H01: There are no significant differences between pretest and posttest in 
knowledge of glaucoma. 
Ha1: There are significant differences between pretest and posttest in knowledge 
of glaucoma. 
To determine whether glaucoma knowledge differed between time points, I 
examined the main effect of time in the repeated measures ANOVA. There was a 
statistically significant main effect of time point, such that glaucoma knowledge was 
significantly different between at least two time points (F(2, 286) = 541.40, p < .001, 
partial η2 = .79). Pairwise dependent t tests indicated that all comparisons between time 




GKI Estimated Marginal Means by Group for All Time Points 
Variable M SE 95% CI 
GKI T1    
Control  4.61 0.18 [4.27, 4.96] 
Intervention 3.95 0.18 [3.61, 4.30] 
GKI T2    
Control  6.60 0.14 [6.32, 6.88] 
Intervention 9.56 0.14 [9.28, 9.84] 
GKI T3    
Control  6.22 0.18 [5.86, 6.59] 
Intervention 8.85 0.17 [8.51, 9.18] 
 
RQ2: Are there significant differences between the two groups in knowledge of 
glaucoma as a function of whether patients are provided with additional education?  
H02: There are no significant differences between the two groups in knowledge of 
glaucoma. 
Ha2: There are significant differences between the two groups in knowledge of 
glaucoma. 
For this research question, I examined the main effect of group from the repeated 
measures ANOVA, where group was the between-subjects variable. There was a 
statistically significant main effect of group, such that Group 1 (M = 5.73, SD = 1.67) 
overall had lower glaucoma knowledge than Group 2 (M = 7.27, SD = 0.97; F(1, 143) = 
56.13, p < .001, partial η2 = .28). 
RQ3: Is there an interaction effect between time and group in knowledge of 
glaucoma as a function of whether patients are provided with additional education?  




Ha3: There is an interaction effect between the time and group in knowledge of 
glaucoma. 
To answer RQ3, I examined the interaction from the repeated measures ANOVA 
between the within-subjects variable of GKI timepoint and the between-subjects variable 
of Group. The Huynh-Feldt correction was the means to account for the violation of 
sphericity. The interaction was significant even with the correction, indicating differences 
between the groups for at least one time point (F(1.61, 229.77) = 134.01, p < .001, partial 
η2 = .48). Table 4 shows the breakdown of estimated marginal means and standard errors 
for condition by each time point. To decompose the interaction, I conducted a simple 
main effect of group at all three time points.  
Figure 7 presents the baseline glaucoma knowledge at T1 for both groups. 
Glaucoma knowledge at T1 was statistically significantly greater in Group 1 compared to 
Group 2 (F(1, 204) = 7.05, p < .01, partial η2 = .03). This difference indicates that despite 




Means for Glaucoma Knowledge at Time 1 by Group 
 
Note. Error bars indicate standard error of the means; ** indicates p < .01. 
Figure 8 shows glaucoma knowledge gathered from both groups (intervention and 
control) at T2. The collection of this time point was on the same day as T1, immediately 
after the eye exam for the control group and after the exam and additional education 
about glaucoma provided by the patient navigator for the intervention group. At T2, 
glaucoma knowledge was significantly higher for the intervention group compared to the 






























Means for Glaucoma Knowledge at Time 2 by Group 
 
Note. Error bars indicate standard error of the means; *** indicates p < .001. 
Figure 9 illustrates means for glaucoma knowledge at T3, as collected for all 
patients at the 1-month follow-up appointment. At T3, the intervention group still 
demonstrated significantly higher knowledge of glaucoma (F(1, 143) = 110.13, p < .001, 
partial η2 = .44. This difference indicates that patients in the intervention group retained 






























Means for Glaucoma Knowledge at Time 3 by Group 
 
Note. Error bars indicate standard error of the means; *** indicates p < .001. 
Figure 10 is a summary of the GKI results at T1, T2, and T3. The figure shows 
that at baseline (T1), the control group (Group 1) had greater glaucoma knowledge than 
the intervention group (Group 2). T2, conducted on the same day as T1, indicates a jump 
in knowledge for both groups, with the intervention group having a greater overall 
increase in knowledge. The figure also shows that at a 1-month follow-up appointment, 
there was a slight decrease in knowledge in both groups from T2, with the intervention 





























Glaucoma Knowledge Index at Time 2 and Time 3 by Group 
 
Note. Error bars indicate standard error of the means; ** indicates p < .01; *** indicates p 
< .001. 
Figure 11 presents the full interaction with marginal means for conditions by each 
time point. The interaction shows that at T1, the control condition scored higher on the 
GKI than the intervention. At T2, the intervention condition scored significantly higher 
on the GKI, and at T3, both conditions dropped while maintaining the differential 





























Marginal Means Interaction 
 
Note. The interaction effect. 
 
RQ4: Is patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up appointment at T3 dependent on whether patients were exposed to education 
about glaucoma? 
H04: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 
follow-up appointment at T3 is not dependent on whether patients were exposed to 
education about glaucoma. 
Ha4: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma 





























To answer RQ4, I performed a chi-square test of independence between the 
variables of group and attendance at the follow-up visit (T3). There was no difference 
between Group 2 and Group 1 attendance for the follow-up glaucoma exam. Marginally, 
more participants in Group 2 attended the 3-month follow-up visit compared to 
participants in Group 1 (χ2 (1) = 2.82, p = .09, V = .12). This was apparent by the p = .09, 
which was larger than the accepted cut-off value of α = .05, making the results not 
statistically significant (Cohen, 1988).  
Table 5 shows the frequency breakdown by group of those who did and did not 
attend the follow-up. The effect size (Cramer’s V) for group’s relationship to follow-up 
attendance was small. According to Cohen (1988), Cramer’s V values of .1 to .3 are 
considered to have a small effect size. Therefore, this study’s Cramer’s V value of .12 
indicates the assumption of no relationship between variables of education about 
glaucoma provided by a patient navigator and patient’s adherence to attending a 




Chi-Square Cell Breakdown for Time 3 Follow-Up Attendance by Group 
Group Attended follow-up Total 
 Did not attend Attended  
Group 1    
Count 36 67 103 
% within Group 35.00% 65.00% 100.00% 
% within Attend 59.00% 46.20% 50.00% 
% of Total 17.50% 32.50% 50.00% 
Group 2    
Count 25 78 103 
% within Group 24.30% 75.70% 100.00% 
% within Attend 41.00% 53.80% 50.00% 
% of Total 12.10% 37.90% 50.00% 
Total    
Count 61 145 206 
% within Group 29.60% 70.40% 100.00% 
% within Attend 100.00% 100.00% 100.00% 
% of Total 29.60% 70.40% 100.00% 
 
RQ5: Is patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 
medication at T3 dependent on whether patients were exposed to education about 
glaucoma? 
H05: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 
medication at T3 is not dependent on whether patients were exposed to education about 
glaucoma. 
Ha5: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular 
medication at T3 is dependent on whether patients were exposed to education about 
glaucoma. 
To answer RQ5, I performed a chi-square test of independence between the 
variables of group and medication adherence reported at the follow-up visit (T3). 
90 
 
Marginally, more participants in Group 2 reported adhering to medication at T3 
compared to participants in Group 1 (χ2(1) = 2.84, p = .09, V = .14). Table 6 shows the 
frequency breakdown of those who did and those who did not adhere to medication by 
Group. The p = .09 was below the accepted convectional industry standard of p < .05, 
making the results not statically significant.  
The effect size (Cramer’s V) for group’s relationship to adherence to using 
prescribed ocular medication was small. According to Cohen (1988), Cramer’s V values 
of .1 to .3 are considered to have a small effect size. Therefore, a Cramer’s V value of .14 
in this study indicates the assumption of no relationship between variables of education 
about glaucoma provided by a patient navigator and patient adherence to using prescribed 
ocular medication. 
Table 6 
Chi-Square Cell Breakdown for Medication by Group 
Group Medication Total 
 Did not adhere Adhered  
Group 1    
Count 20 47 67 
% within Group 29.90% 70.10% 100.00% 
% within Attend 58.80% 42.30% 46.20% 
% of Total 13.80% 32.40% 46.20% 
Group 2    
Count 14 64 78 
% within Group 17.90% 82.10% 100.00% 
% within Attend 41.20% 57.70% 53.80% 
% of Total 9.70% 44.10% 53.80% 
Total    
Count 34 111 145 
% within Group 23.40% 76.60% 100.00% 
% within Attend 100.00% 100.00% 100.00% 





The IV was exposure to education about glaucoma through a patient navigator; 
the DVs were patient knowledge of glaucoma, patient adherence to follow-up visits, and 
patient utilization of prescribed ocular medications. Overall, patient knowledge of 
glaucoma at pretest differed from knowledge at posttest. There was a statistically 
significant main effect of the IV (education about glaucoma through a patient navigator) 
such that the overall intervention group had higher glaucoma knowledge than the control 
group. Additionally, there was a statistically significant interaction between the IV 
(education about glaucoma through a patient navigator) and the time of glaucoma 
knowledge assessment, indicating that the IV effect differed depending on the time point 
of assessing glaucoma knowledge. For example, Group 1 reported more glaucoma 
knowledge at pretest compared to Group 2, whereas Group 2 reported higher glaucoma 
knowledge at both posttest time points. These results indicate a rejection of the null 
hypotheses for RQ1, RQ2, and RQ3. 
RQ4 pertained to examining whether patients’ adherence to attending a glaucoma 
follow-up appointment at T3 was dependent on their exposure to education about 
glaucoma. The results indicate an inability to reject the null hypothesis, which suggests 
that there is no statistically significant relationship between the IV (education about 
glaucoma through a patient navigator) and the DV (patients’ adherence to attending a 
glaucoma follow-up appointment). Patient adherence to follow-up visits was not 
dependent on education about glaucoma provided through a patient navigator. 
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RQ5 was specific to examining whether patients’ adherence to using prescribed 
ocular medication at T3 was dependent on the presence or absence of exposure to 
education about glaucoma. From the results, it was not possible to reject the null 
hypothesis, suggesting that there was no statistically significant relationship between the 
IV (education about glaucoma through a patient navigator) and the DV (patients’ 
adherence to using prescribed ocular medication). Patient utilization of prescribed ocular 
medications was not dependent on education about glaucoma provided through a patient 
navigator.  
Chapter 5 presents a detailed interpretation of the findings within the limits and 
scope of the study. I also discuss the study’s limitations and the implications for social 
change. Following a description of the methodological, theoretical, and empirical 




Chapter 5: Discussion, Conclusions, and Recommendations 
In this study, I sought to determine whether education about glaucoma provided 
by a patient navigator had an effect on patient knowledge about glaucoma as well as 
patient adherence to follow-up visits and medication utilization among Russian Eastern 
European immigrant patients. I used a longitudinal design, incorporating archival data 
from a private glaucoma clinic located in New York. Quantitative research methods were 
appropriate to determine whether there were significant differences between the two 
groups in their knowledge of glaucoma pretest versus posttest as well as whether there 
was an interaction effect between time and group. Additionally, the quantitative approach 
allowed me to determine whether adherence to attending follow-up appointments or 
using prescribed ocular medications were dependent on exposure to education about 
glaucoma. This chapter includes an interpretation of the findings, discussion of 
limitations encountered, recommendations for research, and implications for social 
change resulting from this study.  
Interpretation of Findings 
After receiving Walden University’s IRB approval, I obtained deidentified patient 
data from a private glaucoma clinic in New York. The practice had run a cost-benefit 
analysis of hiring and training a patient navigator to provide education to patients and 
increase the efficiency of patient screening. The clinic collected the data during 
established patients’ regular visits and new patient consultations. The clinic provided me 
with 206 patient records that met the inclusion criteria of (a) Russian immigrant or of that 
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descent, (b) age 45 to 80 years, (c) no known or diagnosed cognitive impairment, and (d) 
and not diagnosed with glaucoma in the past. 
The practice collected, stored, and archived data and subsequently provided them 
to me in an Excel spreadsheet. I conducted the data analyses for this study using SPSS. 
Analyses of the first three research questions were executed by using a repeated measures 
ANOVA, with the fourth and fifth research questions analyzed using a chi-square test of 
independence. In the next section, I discuss the results of these statistical tests in relation 
to the current literature and the study’s research questions.  
Improvement of Glaucoma Knowledge 
Data analysis indicated a significant difference between Group 1 and Group 2 at 
different time points of GKI assessment. Glaucoma knowledge at T1 was statistically 
significantly greater in Group 1 compared to Group 2 (F(1, 204) = 7.05, p < .01, partial 
η2 = .03). This difference indicates that although participants received random group 
assignment, the control group had a slightly higher baseline GKI knowledge score than 
the intervention group. At T2, glaucoma knowledge was significantly higher for the 
intervention group compared to the control group (F(1, 204) = 219.33, p < .001, partial η2 
= .52). The clinic administered the GKI assessment at this time point immediately after 
the eye exam for the control group, and after the exam and additional education about 
glaucoma provided by the patient navigator for the intervention group. At T3, all patients 
completed the GKI to gauge their glaucoma knowledge at their 1-month follow-up 
appointment. The intervention group still demonstrated significantly higher knowledge of 
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glaucoma (F(1, 143) = 110.13, p < .001, partial η2 = .44), indicating they retained the 
increased knowledge about glaucoma at a 1-month follow-up appointment. 
Data analysis showed that educational intervention provided by a patient 
navigator had improved patients’ knowledge about glaucoma, with lasting effects into 
their 1-month follow-up eye appointment. Results from prior studies supported these 
findings, showing that glaucoma education delivered in person through individualized 
counseling was more effective in improving overall glaucoma knowledge in newly 
diagnosed patients than giving patients take-home materials or brochures or having them 
watch videos (McVeigh & Vakros, 2015; Newman-Casey et al., 2015; Okeke et al., 
2009). Gray et al. (2012) randomized 127 newly diagnosed glaucoma patients to a 
personalized, individual health care assessment in addition to standard care or standard 
care with an ophthalmologist. Gray et al.’s intervention began with a 75-minute 
counseling session with a glaucoma nurse to design a 1-year personalized follow-up plan. 
This longitudinal study assessed patient knowledge over 1 year and included five 
appointments with the nurse throughout the year, each lasting 15 to 30 minutes, to further 
educate patients or answer questions. Intervention arm patients had a significantly greater 
knowledge of glaucoma (p < .001) at the end of the study than the control arm. Although 
the intervention proved efficacious when it came to knowledge retention for glaucoma 
patients, the cost-effectiveness of hiring a nurse to spend this time with patients proved 
detrimental to the practice’s financial sustainability. Gray et al. suggested finding less-
involved educational interventions that might not require a full-time nursing position.  
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Building on Gray et al.’s findings, Cate et al. (2014) evaluated a behavior change 
counseling program for 208 newly diagnosed glaucoma patients. The counseling included 
glaucoma education and motivational support from trained paraprofessional staff called 
glaucoma support assistants. Paraprofessional staff attended 7 hours of training about 
glaucoma and its treatment, barriers to adherence, and brief motivational interviewing 
techniques. Patients’ sessions with glaucoma support assistants lasted between 15 and 60 
minutes. There was no statistically significant difference in the proportion of individuals 
with ≥ 80% glaucoma knowledge scores, with 62.5% in the control group and 66.7% in 
the intervention group (p = 0.63). Cate et al. stated that despite finding no additional 
increase in patient education about glaucoma, inexpensively providing information 
tailored to the individual resulted in high patient satisfaction with retaining information 
about glaucoma.  
I evaluated an intervention that was cost-effective and did not warrant a separate 
clinical position to provide educational support to newly diagnosed patients. The 
intervention might have been successful due to the provision of education by a navigator, 
who was a trained optician for many years before shifting into navigating. Last, this 
intervention might have been successful because of the cultural similarity between the 
navigator and the patient population, thereby creating a sense of implicit alliance.  
Adherence to Follow-Up Eye Appointments 
Data analysis for evaluating adherence to attending a glaucoma follow-up 
appointment at T3 indicated no statistically significant difference in Group 1 versus 
Group 2. Marginally, more participants in Group 2 attended the 3-month follow-up visit 
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(p = .09) compared to Group 1 participants. The literature has shown compliance and 
adherence to attending follow-up eye exam appointments as concerns in glaucoma 
treatment (Davis et al., 2018; Johnson et al., 2016; C. X. Zheng et al., 2016). The low 
follow-up rate among newly diagnosed glaucoma patients suggests there could be 
significant barriers affecting follow-up adherence after receiving an ocular diagnosis 
(Newman-Casey, Robin, et al., 2015). Initially, Newman-Casey, Robin, et al. (2015) cited 
a lack of education and patients’ misunderstanding their diagnosis as barriers to attending 
follow-up eye appointments.  
Building on Newman-Casey, Robin, et al.’s (2015) findings, other researchers 
evaluated adherence to follow-up appointment rates with the implementation of an 
educational component into the diagnosis. Hark et al. (2019) found that despite various 
educational interventions, adherence to follow-up appointments was still lacking. Hark et 
al. noted that cultural, racial, and linguistic barriers between health care providers and 
patients significantly affected the quality of health care delivery, ability to access health 
care, and poor health outcomes. Hark et al. evaluated 535 participants, with 172 
randomized to the intervention group and connected with a social worker who provided 
reminder phone calls and transportation assistance to the follow-up appointments. Even 
with the social worker intervention, there was no statistically significant difference 
between the control and intervention groups in adherence to follow-up appointments.  
These results parallel other studies, which have shown forgetfulness and lack of 
education about the importance of attending follow-up eye exam appointments to be the 
most commonly cited reasons for missed eye exam visits (Murchison et al., 2017). Hark 
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et al. (2019) suggested using a culturally competent patient navigator as an educational 
and supportive component of patients’ treatment. Based on these recommendations, I 
attempted to evaluate such a service delivery through a culturally competent patient 
navigator. This study’s findings supported prior research showing that educational 
interventions, although efficacious in improving patients’ understanding and knowledge 
of glaucoma, do not improve patients’ adherence to follow-up eye exam appointments.  
Adherence to Using Prescribed Ocular Medications 
Data analysis for evaluating adherence to using prescribed ocular medications at 
T3 indicated no statistically significant difference in Group 1 versus Group 2. Marginally, 
more participants in Group 2 used their ocular medications (p = .09) compared to 
participants in Group 1. Poor adherence to medication regimens accounted for substantial 
worsening of the disease and increased health care costs (Feehan et al., 2016). 
Researchers have conducted studies to evaluate patients’ adherence to their ocular 
pharmacology treatments (Feehan et al., 2016; McVeigh & Vakros, 2015; 
Movahedinejad & Adib-Hajbaghery, 2016; Newman-Casey, Robin, et al., 2015; Okeke et 
al., 2009). In one of the largest multisite studies, P. F. Cook et al. (2015) reported that 
demographic variables, such as age, gender, and occupation, cannot significantly predict 
patients’ adherence to glaucoma treatment. Although the inconsistencies between studies 
could be due to the populations’ characteristics, as patients age they encounter problems, 
such as hand tremors and memory loss, which might negatively affect their ability to use 
topical eye medications, thereby decreasing adherence. 
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Patient self-reporting was an indirect method of assessing adherence to ocular 
medication. Other data came from physicians’ measurement of ocular pressure during the 
visit to confirm the pharmacological suitability of the prescribed medication. Sayner et al. 
(2015) highlighted particular trends in patients’ compliance. Monnette et al. (2018) 
demonstrated that patient adherence with medication improved in the 5 days before and 
after the appointment with their physician. According to Newman-Casey, Robin, et al. 
(2015), eye drops are far more challenging to self-administer than other medications 
because they require physical coordination, manual dexterity, hand-eye coordination, and 
good vision, all of which tend to decrease in aging glaucoma patients. Scholars have also 
shown that adding a second medication and/or increasing the complexity of glaucoma 
therapy is associated with a statistically significant decrease in adherence (Frech et al., 
2018).  
I did not evaluate any of the contributing factors to the reasons for ocular 
medication noncompliance. However, it is important to note that although the services of 
a culturally competent patent navigator assisted patients in retaining glaucoma knowledge 
at a 1-month follow-up, there was no statistically significant change in adherence to 
medication use according to patient self-report. The study’s findings indicate the 
difficulty of improving adherence in an asymptomatic disease that requires lifelong 
therapy. 
Limitations of the Study 
The present study had several limitations. First, there were limitations associated 
with using archival data because not directly obtaining information leads to an inability to 
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establish authenticity. Second, there is limited generalizability of findings because the 
sample did not reflect the general population, instead consisting only of Russian 
immigrants residing in New York. A single glaucoma specialty practice provided 
participant data, indicating convenience sampling for data collection. Because the patient 
navigator was a Russian immigrant, possible positive cultural bias could have been a 
limitation if participants wanted to please the patient navigator and put forth more effort 
than they would have engaged in otherwise. Finally, multiple barriers unrelated to 
adherence might have prevented participants from attending follow-up exams, such as 
participant mortality, illness, or inability to get transportation, all of which went 
unassessed. Due to cultural differences, the present study’s findings are not generalizable 
to other populations.  
Archival data presented a significant limitation. Using archival, or secondary, data 
means the researcher has not obtained the information directly; therefore, I could not 
ensure the results were entirely accurate, limiting the study. Using archived data presents 
concerns, including the inability to establish authenticity (Frankfort-Nachmias & 
Nachmias, 2008). Authentic research refers to research that is genuine, representing an 
actual data set and not a reproduction or copy. Because I did not collect the data directly, 
establishing authenticity was not possible. 
Additionally, there was a potential for selection bias, which would skew the study 
results. Selection bias occurs in the absence of sample randomization, with convenience 
sampling leading to uncontrolled population variables (Creswell, 2012). The conveniecne 
smaple of 206 participants was randomly split into two groups, Group 1 and Group 2, 
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with equal sample size of 103 participants in each. One variable not controlled in the 
study was participants who might have been more health conscious and eager to adhere to 
the study protocol. Using a convenience sample could also affect the statistical analysis 
due to the lack of randomization. Researchers using a nonrandom sample cannot 
eliminate systematic bias from the selection procedure or estimate parameters of the data 
such that the findings obtained are representative of the overall population (Frankfort-
Nachmias & Nachmias, 2008). 
The lack of a standardized patient navigator protocol for the time spent with the 
patient limited replicability, as necessary, to ascertain external validity and 
generalizability of the findings. Variables such as actual time spent with the patient 
navigator, frequency and duration of interappointment phone calls, appointment 
reminders, leaving accurate messages, and inability to assess reasons for missing 
appointments affected the reliability of the results. Also not controlled for were the 
patient navigator’s gender and cultural background, factors that might have influenced 
participants’ behavior and answers. Moreover, the patient navigator did not adhere to a 
rigid script during patient appointments, likely varying the discussion based on patients’ 
needs. The patient navigator made a unilateral decision regarding what to address with 
each patient, thereby reducing the procedure’s validity and replicability.  
The data files were in an encrypted Excel spreadsheet extracted from the 
practice’s REDCap database. I manually scanned the spreadsheet for new patients only, 
omitting the existing patients’ information. Next, I recorded the data by their corrected 
answers, uploading a new Excel spreadsheet into SPSS for data analysis. By using these 
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techniques, I was able to minimize limitations and concerns for the study, such as data 
contamination from existing patients. The results from this study were consistent with the 
findings in the literature, which showed that improved patient knowledge and 
understanding of glaucoma is independent of patients’ adherence to follow-up 
appointments and use of prescribed ocular medications.  
Recommendations 
The findings indicated areas for future research, including the study design. My 
study population had similar ethnic identification distributions and was isolated to a 
localized area in New York. The generalizability of results is low due to the homogeneity 
of the population. Studies incorporating broader demographics and diverse ethnic and 
racial backgrounds would allow for increased confidence in generalizing results to 
populations with similar ethnic identities.  
Previous research has shown that providing knowledge and educating patients 
about glaucoma did not have a significant effect on improving their adherence to follow-
up care or utilization of ocular medications. Despite prior assumptions that providing and 
improving strategies to educate patients about their condition would increase patient 
adherence to prescribed treatment, this belief is unsupported. Future studies on improving 
ways to engage patients in their own care are necessary. Further research could also focus 
on interventions targeting adherence to follow-up care and using ocular medications 
independently, without focusing on educational strategies.  
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Implications for Social Change 
Glaucoma is a chronic, progressive, and asymptomatic disease and is the second 
leading cause of preventable blindness worldwide (Newman-Casey, Blanchey, et al., 
2015). Timely, effective, and successful treatment is necessary to reduce intraocular 
pressure and minimize glaucoma development and progression (Gupta et al., 2016; Hark 
et al., 2017). Achieving these outcomes entails frequent follow-up eye exams and eye 
drop administration (Gupta et al., 2016). However, adherence to medical therapies is 
notoriously poor, with reported nonadherence rates ranging from 30% to 80% (Prum et 
al., 2016). Poor adherence is associated with disease progression and blindness, leading 
to significant personal, societal, and economic burdens, such as the loss of health-related 
quality of life (Tan et al., 2018; D. D. Zheng et al., 2018). Ongoing visual field loss can 
impair patients’ abilities to perform everyday activities through substantially reduced 
mobility, more falls and unnecessary trips to the hospital, and negative psychological 
effects (D. D. Zheng et al., 2018).  
The financial burden of glaucoma rises along with disease severity. Gupta et al. 
(2016) found a fourfold increase in direct ophthalmology-related costs as severity 
increased from asymptomatic ocular hypertension/earliest glaucoma (Stage 0) through 
advanced glaucoma (Stage 3) to end-stage glaucoma/blindness (Stage 5). The average 
direct costs per patient per year were $623, $1,915, and $2,511, respectively (Feldman et 
al., 2020; Gupta et al., 2016; Varma et al., 2011; Yang et al., 2019). The majority of costs 
were medication-related at all severity stages. Individuals with late-stage disease incur 
additional indirect costs, placing a substantial burden on health care resources. Late 
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disease leads to greater indirect costs, such as family and home help and rehabilitation 
costs, which become the predominant driver of overall expense (Feldman et al., 2020). 
This study contributed to positive social change. I addressed the literature gap, 
investigating a specialized, culturally competent educational intervention provided to 
newly diagnosed glaucoma patients to evaluate its effect on improving clinical 
management of glaucoma. The positive impact at the individual level could be a 
healthier, happier, and more productive person; at the health care delivery level, the 
findings could contribute to creating a model of care that is empowered, informed, and 
patient-centered; and at the economic level, the findings indicate a need to allocate 
resources for more imminent issues affecting the health care of the general population. 
This study’s outcomes could form the basis for serious discussions among policymakers. 
The study might also enhance the awareness of physicians and the public about the 
burden of glaucoma, prioritizing glaucoma care and treatment. Implications for further 
scientific investigations include broadly exploring factors affecting nonadherence in 
glaucoma patients and ways to improve adherence among the targeted population.  
Conclusion 
Glaucoma is a growing problem. It is common, often underdiagnosed, costly, 
distressing to patients and families, and disabling. As glaucoma prevalence increases 
exponentially with age, its incidence is rising among the rapidly aging population 
(Fenwick et al., 2020). Economic and individual costs increase with disease severity; 
however, proactive glaucoma management can reduce the overall disease burden. Early 
identification and treatment of patients with glaucoma and those with ocular hypertension 
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at high risk of developing vision loss can reduce the individual burden of disease on 
health-related quality of life and minimize personal and societal economic burdens. 
This study showed that an in-person, individualized educational session provided 
by a culturally competent patient navigator was effective in improving patients’ 
knowledge and understanding about the disease well into their 1-month follow-up 
appointment. However, this knowledge was independent of the patients’ adherence to 
attending a follow-up appointment or using their ocular drops. This study showed that 
each patient is likely to have a unique set of issues to address to optimize adherence. It is 
possible that the greater the number of barriers identified, the greater the likelihood of 
nonadherence (see Newman-Casey, Robin, et al., 2015). It was possible to predict 
nonadherent behavior according to the TTM, or the stages of change, indicating 
individuals’ enormous capacity to change harmful or undesirable behavior (DiClemente 
& Prochaska, 1982, 1998; Prochaska & Vellcer, 1997). Interventions focused on 
improving adherence should build self-efficacy, teach patients proper eye drop 
instillation, and address forgetfulness and difficulties with the medication schedule 
(Feehan et al., 2016). Providers should individualize interventions, tailoring information 
and approaches to address each patient’s unique set of barriers. All health care providers 
should pay attention to their patients’ predictive adherent behaviors to identify the best 
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